hun20230331_10q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Form 10-Q

(Mark One)
☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2023

OR

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number	Exact Name of Registrant as Specified in its Charter, Principal Office Address and Telephone Number	State of Incorporation or Organization	I.R.S. Employer Identification No.
001-32427	Huntsman Corporation 10003 Woodloch Forest Drive The Woodlands, Texas 77380 (281) 719-6000	Delaware	42-1648585
333-85141	Huntsman International LLC 10003 Woodloch Forest Drive The Woodlands, Texas 77380 (281) 719-6000	Delaware	87-0630358

Securities registered pursuant to Section 12(b) of the Act:

Registrant	Title of each class	Trading Symbol	Name of each exchange on which registered
Huntsman Corporation	Common Stock, par value $0.01 per share	HUN	New York Stock Exchange
Huntsman International LLC	NONE	NONE	NONE

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Huntsman Corporation	Yes ☒	No ☐
Huntsman International LLC	Yes ☒	No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Huntsman Corporation	Yes ☒	No ☐
Huntsman International LLC	Yes ☒	No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Huntsman Corporation	Large accelerated filer ☒	Accelerated filer ☐	Non-accelerated filer ☐	Smaller reporting company ☐	Emerging growth company ☐
Huntsman International LLC	Large accelerated filer ☐	Accelerated filer ☐	Non-accelerated filer ☒	Smaller reporting company ☐	Emerging Growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Huntsman Corporation		☐
Huntsman International LLC		☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Huntsman Corporation	Yes ☐	No ☒
Huntsman International LLC	Yes ☐	No ☒

On April 25, 2023, 181,183,489 shares of common stock of Huntsman Corporation were outstanding and 2,728 units of membership interest of Huntsman International LLC were outstanding. There is no trading market for Huntsman International LLC’s units of membership interest. All of Huntsman International LLC’s units of membership interest are held by Huntsman Corporation.

This Quarterly Report on Form 10-Q presents information for two registrants: Huntsman Corporation and Huntsman International LLC. Huntsman International LLC is a wholly-owned subsidiary of Huntsman Corporation and is the principal operating company of Huntsman Corporation. The information reflected in this Quarterly Report on Form 10-Q is equally applicable to both Huntsman Corporation and Huntsman International LLC, except where otherwise indicated. Huntsman International LLC meets the conditions set forth in General Instructions H(1)(a) and (b) of Form 10-Q and, to the extent applicable, is therefore filing this form with a reduced disclosure format.

Table of Contents

HUNTSMAN CORPORATION AND SUBSIDIARIES

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTERLY PERIOD

ENDED March 31, 2023

TABLE OF CONTENTS

		Page
PART I	FINANCIAL INFORMATION	4
ITEM 1.	Condensed Consolidated Financial Statements (Unaudited)	4
	Huntsman Corporation and Subsidiaries:
	Unaudited Condensed Consolidated Balance Sheets	4
	Unaudited Condensed Consolidated Statements of Operations	5
	Unaudited Condensed Consolidated Statements of Comprehensive Income	6
	Unaudited Condensed Consolidated Statements of Equity	7
	Unaudited Condensed Consolidated Statements of Cash Flows	8
	Huntsman International LLC and Subsidiaries:
	Unaudited Condensed Consolidated Balance Sheets	9
	Unaudited Condensed Consolidated Statements of Operations	10
	Unaudited Condensed Consolidated Statements of Comprehensive Income	11
	Unaudited Condensed Consolidated Statements of Equity	12
	Unaudited Condensed Consolidated Statements of Cash Flows	13
	Huntsman Corporation and Subsidiaries and Huntsman International LLC and Subsidiaries:
	Notes to Unaudited Condensed Consolidated Financial Statements	14
ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	33
ITEM 3.	Quantitative and Qualitative Disclosures About Market Risk	44
ITEM 4.	Controls and Procedures	44
PART II	OTHER INFORMATION	45
ITEM 1.	Legal Proceedings	45
ITEM 1A.	Risk Factors	45
ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	45
ITEM 6.	Exhibits	46

Table of Contents

FORWARD-LOOKING STATEMENTS

Certain information set forth in this report contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than historical factual information are forward-looking statements, including without limitation statements regarding: projections of revenue, expenses, profit, profit margins, tax rates, tax provisions, cash flows, pension and benefit obligations and funding requirements, our liquidity position or other projected financial measures; management’s plans and strategies for future operations, including statements relating to anticipated operating performance, cost reductions, restructuring activities, new product and service developments, competitive strengths or market position, acquisitions, divestitures, spin-offs or other distributions, strategic opportunities, securities offerings, stock repurchases, dividends and executive compensation; growth, declines and other trends in markets we sell into; new or modified laws, regulations and accounting pronouncements; outstanding claims, legal proceedings, tax audits and assessments and other contingent liabilities; foreign currency exchange rates and fluctuations in those rates; general economic and capital markets conditions; the timing of any of the foregoing; assumptions underlying any of the foregoing; and any other statements that address events or developments that we intend or believe will or may occur in the future. In some cases, forward-looking statements can be identified by terminology such as “believes,” “expects,” “may,” “will,” “should,” “anticipates” or “intends” or the negative of such terms or other comparable terminology, or by discussions of strategy. We may also make additional forward-looking statements from time to time. All such subsequent forward-looking statements, whether written or oral, by us or on our behalf, are also expressly qualified by these cautionary statements.

All forward-looking statements, including without limitation any projections derived from management’s examination of historical operating trends, are based upon our current expectations and various assumptions. Our expectations, beliefs and projections are expressed in good faith and we believe there is a reasonable basis for them, but there can be no assurance that management’s expectations, beliefs and projections will be achieved. All forward-looking statements apply only as of the date made. We undertake no obligation to publicly update or revise forward-looking statements whether because of new information, future events or otherwise, except as required by securities and other applicable law.

There are a number of risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements contained in or contemplated by this report. Any forward-looking statements should be considered in light of the risks set forth in “Part II. Item 1A. Risk Factors” below and “Part I. Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022.

Table of Contents

PART I. FINANCIAL INFORMATION

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

HUNTSMAN CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(In Millions, Except Share and Per Share Amounts)

	*March 31,*			*December 31,*
	*2023*			*2022*
ASSETS
Current assets:
Cash and cash equivalents(a)	$	615		$	654
Accounts and notes receivable (net of allowance for doubtful accounts of $13 and $14, respectively), ($306 and $272 pledged as collateral, respectively)(a)		878			813
Accounts receivable from affiliates		9			21
Inventories(a)		1,048			995
Other current assets		150			190
Current assets held for sale		—			472
Total current assets		2,700			3,145
Property, plant and equipment, net(a)		2,366			2,377
Investment in unconsolidated affiliates		441			425
Intangible assets, net		415			425
Goodwill		642			641
Deferred income taxes		136			147
Operating lease right-of-use assets		367			374
Other noncurrent assets(a)		696			686
Total assets	$	7,763		$	8,220

LIABILITIES AND EQUITY
Current liabilities:
Accounts payable(a)	$	791		$	907
Accounts payable to affiliates		66			54
Accrued liabilities(a)		381			429
Current portion of debt(a)		11			66
Current operating lease liabilities(a)		48			51
Current liabilities held for sale		—			194
Total current liabilities		1,297			1,701
Long-term debt(a)		1,509			1,671
Deferred income taxes		238			250
Noncurrent operating lease liabilities(a)		334			336
Other noncurrent liabilities(a)		395			422
Total liabilities		3,773			4,380
Commitments and contingencies (Notes 14 and 15)
Equity
Huntsman Corporation stockholders’ equity:
Common stock $0.01 par value, 1,200,000,000 shares authorized, 261,880,013 and 261,148,217 shares issued and 180,894,240 and 183,634,464 shares outstanding, respectively		3			3
Additional paid-in capital		4,195			4,156
Treasury stock, 80,985,773 and 77,513,753 shares, respectively		(2,038	)		(1,937	)
Unearned stock-based compensation		(58	)		(35	)
Retained earnings		2,804			2,705
Accumulated other comprehensive loss		(1,143	)		(1,268	)
Total Huntsman Corporation stockholders’ equity		3,763			3,624
Noncontrolling interests in subsidiaries		227			216
Total equity		3,990			3,840
Total liabilities and equity	$	7,763		$	8,220

(a)

At March 31, 2023 and December 31, 2022, respectively, $12 and $5 of cash and cash equivalents, $6 and $4 of accounts and notes receivable (net), $57 and $59 of inventories, $147 and $149 of property, plant and equipment (net), $29 each of other noncurrent assets, $97 and $114 of accounts payable, $13 and $12 of accrued liabilities, $9 each of current portion of debt, $10 and $9 of current operating lease liabilities, $24 and $26 of long-term debt, $18 and $19 of noncurrent operating lease liabilities and $24 and $25 of other noncurrent liabilities from consolidated variable interest entities are included in the respective balance sheet captions above. See “Note 5. Variable Interest Entities.” These assets can only be used to settle obligations of the variable interest entities, and creditors of these liabilities do not have recourse to our general credit.

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In Millions, Except Per Share Amounts)

	*Three months*
	*ended*
	*March 31,*
	*2023*			*2022*
Revenues:
Trade sales, services and fees, net	$	1,573		$	2,132
Related party sales		33			60
Total revenues		1,606			2,192
Cost of goods sold		1,337			1,677
Gross profit		269			515
Operating expenses:
Selling, general and administrative		188			190
Research and development		30			34
Restructuring, impairment and plant closing credits		(7	)		—
Other operating (income) expense, net		(3	)		8
Total operating expenses		208			232
Operating income		61			283
Interest expense, net		(18	)		(14	)
Equity in income of investment in unconsolidated affiliates		12			15
Fair value adjustments to Venator investment, net		(1	)		(2	)
Other income, net		1			—
Income from continuing operations before income taxes		55			282
Income tax expense		(11	)		(60	)
Income from continuing operations		44			222
Income from discontinued operations, net of tax		122			18
Net income		166			240
Net income attributable to noncontrolling interests		(13	)		(17	)
Net income attributable to Huntsman Corporation	$	153		$	223

Basic income per share:
Income from continuing operations attributable to Huntsman Corporation common stockholders	$	0.17		$	0.96
Income from discontinued operations attributable to Huntsman Corporation common stockholders, net of tax		0.67			0.09
Net income attributable to Huntsman Corporation common stockholders	$	0.84		$	1.05
Weighted average shares		182.7			212.7

Diluted income per share:
Income from continuing operations attributable to Huntsman Corporation common stockholders	$	0.17		$	0.95
Income from discontinued operations attributable to Huntsman Corporation common stockholders, net of tax		0.66			0.09
Net income attributable to Huntsman Corporation common stockholders	$	0.83		$	1.04
Weighted average shares		184.4			215.4

Amounts attributable to Huntsman Corporation:
Income from continuing operations	$	31		$	205
Income from discontinued operations, net of tax		122			18
Net income	$	153		$	223

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In Millions)

	*Three months*
	*ended*
	*March 31,*
	*2023*			*2022*
Net income	$	166		$	240
Other comprehensive income (loss), net of tax:
Foreign currency translations adjustments		54			(20	)
Pension and other postretirement benefits adjustments		74			9
Other, net		(1	)		(1	)
Other comprehensive income (loss), net of tax		127			(12	)
Comprehensive income		293			228
Comprehensive income attributable to noncontrolling interests		(15	)		(16	)
Comprehensive income attributable to Huntsman Corporation	$	278		$	212

Table of Contents

HUNTSMAN CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

(In Millions, Except Share Amounts)

	*Huntsman Corporation Stockholders' Equity*
																	*Accumulated*
	*Shares*					*Additional*					*Unearned*						*other*			*Noncontrolling*
	*common*			*Common*		*paid-in*		*Treasury*			*stock-based*			*Retained*			*comprehensive*			*interests in*			*Total*
	*stock*			*stock*		*capital*		*stock*			*compensation*			*earnings*			*loss*			*subsidiaries*			*equity*
Balance, January 1, 2023		183,634,464		$	3	$	4,156	$	(1,937	)	$	(35	)	$	2,705		$	(1,268	)	$	216		$	3,840
Net income		—			—		—		—			—			153			—			13			166
Other comprehensive income		—			—		—		—			—			—			125			2			127
Issuance of nonvested stock awards		—			—		32		—			(32	)		—			—			—			—
Vesting of stock awards		1,016,782			—		5		—			—			—			—			—			5
Recognition of stock-based compensation		—			—		1		—			9			—			—			—			10
Repurchase and cancellation of stock awards		(301,231	)		—		—		—			—			(9	)		—			—			(9	)
Stock options exercised		16,245			—		1		—			—			(1	)		—			—			—
Treasury stock repurchased		(3,472,020	)		—		—		(101	)		—			—			—			—			(101	)
Distributions to noncontrolling interests		—			—		—		—			—			—			—			(4	)		(4	)
Dividends declared on common stock ($0.2375 per share)		—			—		—		—			—			(44	)		—			—			(44	)
Balance, March 31, 2023		180,894,240		$	3	$	4,195	$	(2,038	)	$	(58	)	$	2,804		$	(1,143	)	$	227		$	3,990

	*Huntsman Corporation Stockholders' Equity*
																	*Accumulated*
	*Shares*					*Additional*					*Unearned*						*other*			*Noncontrolling*
	*common*			*Common*		*paid-in*		*Treasury*			*stock-based*			*Retained*			*comprehensive*			*interests in*			*Total*
	*stock*			*stock*		*capital*		*stock*			*compensation*			*earnings*			*loss*			*subsidiaries*			*equity*
Balance, January 1, 2022		214,170,287		$	3	$	4,102	$	(934	)	$	(25	)	$	2,435		$	(1,203	)	$	181		$	4,559
Net income		—			—		—		—			—			223			—			17			240
Other comprehensive loss		—			—		—		—			—			—			(11	)		(1	)		(12	)
Issuance of nonvested stock awards		—			—		32		—			(32	)		—			—			—			—
Vesting of stock awards		1,327,568			—		7		—			—			—			—			—			7
Recognition of stock-based compensation		—			—		1		—			8			—			—			—			9
Repurchase and cancellation of stock awards		(361,250	)		—		—		—			—			(13	)		—			—			(13	)
Stock options exercised		387,899			—		10		—			—			(5	)		—			—			5
Treasury stock repurchased		(5,549,348	)		—		—		(210	)		—			—			—			—			(210	)
Dividends declared on common stock ($0.2125 per share)		—			—		—		—			—			(45	)		—			—			(45	)
Balance, March 31, 2022		209,975,156		$	3	$	4,152	$	(1,144	)	$	(49	)	$	2,595		$	(1,214	)	$	197		$	4,540

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Millions)

	*Three months*
	*ended*
	*March 31,*
	*2023*			*2022*
Operating Activities:
Net income	$	166		$	240
Less: Income from discontinued operations, net of tax		(122	)		(18	)
Income from continuing operations		44			222
Adjustments to reconcile income from continuing operations to net cash (used in) provided by operating activities from continuing operations:
Equity in income of investment in unconsolidated affiliates		(12	)		(15	)
Unrealized net losses on fair value adjustments to Venator investment, net		1			2
Depreciation and amortization		69			67
Noncash lease expense		17			15
Deferred income taxes		(20	)		12
Noncash stock-based compensation		9			10
Other, net		(1	)		1
Changes in operating assets and liabilities:
Accounts and notes receivable		(23	)		(119	)
Inventories		(50	)		(158	)
Other current assets		23			13
Other noncurrent assets		(17	)		(1	)
Accounts payable		(75	)		77
Accrued liabilities		(70	)		(31	)
Other noncurrent liabilities		(17	)		(28	)
Net cash (used in) provided by operating activities from continuing operations		(122	)		67
Net cash (used in) provided by operating activities from discontinued operations		(32	)		18
Net cash (used in) provided by operating activities		(154	)		85

Investing Activities:
Capital expenditures		(46	)		(64	)
Cash received from sale of businesses, net		541			—
Other, net		(2	)		4
Net cash provided by (used in) investing activities from continuing operations		493			(60	)
Net cash used in investing activities from discontinued operations		(4	)		(5	)
Net cash provided by (used in) investing activities		489			(65	)

Financing Activities:
Net (repayments) borrowings on revolving loan facilities		(220	)		8
Repayments of long-term debt		(4	)		(3	)
Dividends paid to common stockholders		(44	)		(46	)
Distributions paid to noncontrolling interests		(4	)		—
Repurchase and cancellation of awards		(9	)		(13	)
Repurchase of common stock		(97	)		(203	)
Proceeds from issuance of common stock		—			5
Other, net		(1	)		—
Net cash used in financing activities		(379	)		(252	)
Effect of exchange rate changes on cash		5			(2	)
Decrease in cash and cash equivalents		(39	)		(234	)
Cash and cash equivalents at beginning of period		654			1,041
Cash and cash equivalents at end of period	$	615		$	807

Supplemental cash flow information:
Cash paid for interest	$	10		$	9
Cash paid for income taxes		29			32

As of March 31, 2023 and 2022, the amount of capital expenditures in accounts payable was $21 million and $41 million, respectively.

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(In Millions, Except Unit Amounts)

	*March 31,*			*December 31,*
	*2023*			*2022*
ASSETS
Current assets:
Cash and cash equivalents(a)	$	615		$	654
Accounts and notes receivable (net of allowance for doubtful accounts of $13 and $14, respectively), ($306 and $272 pledged as collateral, respectively)(a)		878			813
Accounts receivable from affiliates		9			21
Inventories(a)		1,048			995
Other current assets		150			196
Current assets held for sale		—			472
Total current assets		2,700			3,151
Property, plant and equipment, net(a)		2,366			2,377
Investment in unconsolidated affiliates		441			425
Intangible assets, net		415			425
Goodwill		642			641
Deferred income taxes		136			147
Operating lease right-of-use assets		367			374
Other noncurrent assets(a)		696			686
Total assets	$	7,763		$	8,226

LIABILITIES AND EQUITY
Current liabilities:
Accounts payable(a)	$	787		$	907
Accounts payable to affiliates		66			54
Accrued liabilities(a)		374			427
Current portion of debt(a)		11			66
Current operating lease liabilities(a)		48			51
Current liabilities held for sale		—			194
Total current liabilities		1,286			1,699
Long-term debt(a)		1,509			1,671
Deferred income taxes		242			254
Noncurrent operating lease liabilities(a)		334			336
Other noncurrent liabilities(a)		390			414
Total liabilities		3,761			4,374
Commitments and contingencies (Notes 14 and 15)
Equity
Huntsman International LLC members’ equity:
Members’ equity, 2,728 units issued and outstanding		3,769			3,759
Retained earnings		1,133			1,130
Accumulated other comprehensive loss		(1,127	)		(1,253	)
Total Huntsman International LLC members’ equity		3,775			3,636
Noncontrolling interests in subsidiaries		227			216
Total equity		4,002			3,852
Total liabilities and equity	$	7,763		$	8,226

(a)

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In Millions)

	*Three months*
	*ended*
	*March 31,*
	*2023*			*2022*
Revenues:
Trade sales, services and fees, net	$	1,573		$	2,132
Related party sales		33			60
Total revenues		1,606			2,192
Cost of goods sold		1,337			1,677
Gross profit		269			515
Operating expenses:
Selling, general and administrative		186			187
Research and development		30			34
Restructuring, impairment and plant closing credits		(7	)		—
Other operating (income) expense, net		(3	)		8
Total operating expenses		206			229
Operating income		63			286
Interest expense, net		(18	)		(14	)
Equity in income of investment in unconsolidated affiliates		12			15
Fair value adjustments to Venator investment, net		(1	)		(2	)
Other income, net		1			—
Income from continuing operations before income taxes		57			285
Income tax expense		(11	)		(60	)
Income from continuing operations		46			225
Income from discontinued operations, net of tax		122			18
Net income		168			243
Net income attributable to noncontrolling interests		(13	)		(17	)
Net income attributable to Huntsman International LLC	$	155		$	226

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In Millions)

	*Three months*
	*ended*
	*March 31,*
	*2023*			*2022*
Net income	$	168		$	243
Other comprehensive income (loss), net of tax:
Foreign currency translations adjustments		54			(20	)
Pension and other postretirement benefits adjustments		74			9
Other, net		—			(1	)
Other comprehensive income (loss), net of tax		128			(12	)
Comprehensive income		296			231
Comprehensive income attributable to noncontrolling interests		(15	)		(16	)
Comprehensive income attributable to Huntsman International LLC	$	281		$	215

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

(In Millions, Except Unit Amounts)

	*Huntsman International LLC Members*
	*Members'*							*Accumulated other*			*Noncontrolling*
	*equity*							*comprehensive*			*interests in*			*Total*
	*Units*		*Amount*		*Retained earnings*			*loss*			*subsidiaries*			*equity*
Balance, January 1, 2023		2,728	$	3,759	$	1,130		$	(1,253	)	$	216		$	3,852
Net income		—		—		155			—			13			168
Dividends paid to parent		—		—		(43	)		—			—			(43	)
Other comprehensive income		—		—		—			126			2			128
Contribution from parent		—		10		—			—			—			10
Distribution to parent		—		—		(109	)		—			—			(109	)
Distributions to noncontrolling interests		—		—		—			—			(4	)		(4	)
Balance, March 31, 2023		2,728		3,769		1,133			(1,127	)		227			4,002

	*Huntsman International LLC Members*
	*Members'*							*Accumulated other*			*Noncontrolling*
	*equity*							*comprehensive*			*interests in*			*Total*
	*Units*		*Amount*		*Retained earnings*			*loss*			*subsidiaries*			*equity*
Balance, January 1, 2022		2,728	$	3,732	$	2,093		$	(1,187	)	$	181		$	4,819
Net income		—		—		226			—			17			243
Dividends paid to parent		—		—		(45	)		—			—			(45	)
Other comprehensive loss		—		—		—			(11	)		(1	)		(12	)
Contribution from parent		—		9		—			—			—			9
Balance, March 31, 2022		2,728	$	3,741	$	2,274		$	(1,198	)	$	197		$	5,014

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Millions)

	*Three months*
	*ended*
	*March 31,*
	*2023*			*2022*
Operating Activities:
Net income	$	168		$	243
Less: Income from discontinued operations, net of tax		(122	)		(18	)
Income from continuing operations		46			225
Adjustments to reconcile income from continuing operations to net cash (used in) provided by operating activities from continuing operations:
Equity in income of investment in unconsolidated affiliates		(12	)		(15	)
Unrealized net losses on fair value adjustments to Venator investment, net		1			2
Depreciation and amortization		69			67
Noncash lease expense		17			15
Deferred income taxes		(19	)		12
Noncash stock-based compensation		8			8
Other, net		(4	)		3
Changes in operating assets and liabilities:
Accounts and notes receivable		(23	)		(119	)
Inventories		(50	)		(158	)
Other current assets		29			12
Other noncurrent assets		(17	)		(1	)
Accounts payable		(75	)		76
Accrued liabilities		(75	)		(31	)
Other noncurrent liabilities		(17	)		(28	)
Net cash (used in) provided by operating activities from continuing operations		(122	)		68
Net cash (used in) provided by operating activities from discontinued operations		(32	)		18
Net cash (used in) provided by operating activities		(154	)		86

Investing Activities:
Capital expenditures		(46	)		(64	)
Cash received from sale of businesses, net		541			—
Increase in receivable from affiliate		(109	)		(212	)
Other, net		(1	)		3
Net cash provided by (used in) investing activities from continuing operations		385			(273	)
Net cash used in investing activities from discontinued operations		(4	)		(5	)
Net cash provided by (used in) investing activities		381			(278	)

Financing Activities:
Net (repayments) borrowings on revolving loan facilities		(220	)		8
Repayments of long-term debt		(4	)		(3	)
Dividends paid to parent		(43	)		(45	)
Distributions paid to noncontrolling interests		(4	)		—
Other, net		—			1
Net cash used in financing activities		(271	)		(39	)
Effect of exchange rate changes on cash		5			(2	)
Decrease in cash and cash equivalents		(39	)		(233	)
Cash and cash equivalents at beginning of period		654			1,039
Cash and cash equivalents at end of period	$	615		$	806

Supplemental cash flow information:
Cash paid for interest	$	10		$	9
Cash paid for income taxes		29			32

As of March 31, 2023 and 2022, the amount of capital expenditures in accounts payable was $21 million and $41 million, respectively.

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN CORPORATION AND SUBSIDIARIES

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1. GENERAL

Certain Definitions

For convenience in this report, the terms “Company,” “Huntsman,” “our,” “us” or “we” may be used to refer to Huntsman Corporation and, unless the context otherwise requires, its subsidiaries and predecessors. In this report, “Huntsman International” refers to Huntsman International LLC (our wholly-owned subsidiary).

In this report, we may use, without definition, the common names of competitors or other industry participants. We may also use the common names or abbreviations for certain chemicals or products.

Interim Financial Statements

Our unaudited interim condensed consolidated financial statements and Huntsman International’s unaudited interim condensed consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP” or “U.S. GAAP”) and in management’s opinion reflect all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of results of operations, comprehensive income, financial position and cash flows for the periods presented. Results for interim periods are not necessarily indicative of those to be expected for the full year. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes to consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2022 for our Company and Huntsman International.

Description of Businesses

We are a global manufacturer of diversified organic chemical products. We operate in three segments: Polyurethanes, Performance Products and Advanced Materials. Our products comprise many different chemicals and formulations, which we market globally to a wide range of consumers that consist primarily of industrial and building product manufacturers. Our products are used in a broad range of applications, including those in the adhesives, aerospace, automotive, coatings and construction, construction products, durable and non-durable consumer products, electronics, insulation, packaging, power generation and refining. Many of our products offer effects such as premium insulation in homes and buildings and the light weighting of airplanes and automobiles that help conserve energy. We are a leading global producer in many of our key product lines, including MDI, amines, maleic anhydride and epoxy-based polymer formulations. We operate all of our businesses through Huntsman International, our wholly-owned subsidiary. Huntsman International is a Delaware limited liability company and was formed in 1999.

Huntsman Corporation and Huntsman International Financial Statements

Except where otherwise indicated, these notes relate to the condensed consolidated financial statements for both our Company and Huntsman International. The differences between our condensed consolidated financial statements and Huntsman International’s condensed consolidated financial statements relate primarily to different capital structures and purchase accounting recorded at our Company for the 2003 step-acquisition of Huntsman International Holdings LLC, the former parent company of Huntsman International that was merged into Huntsman International in 2005.

Principles of Consolidation

Our condensed consolidated financial statements include the accounts of our wholly-owned and majority-owned subsidiaries and any variable interest entities for which we are the primary beneficiary. Intercompany accounts and transactions have been eliminated.

Reclassfications

Certain amounts in the condensed consolidated financial statements for prior periods have been recast to present the results of operations of our textile chemicals and dyes business (“Textile Effects Business”) as discontinued operations. For more information, see “Note 3. Discontinued Operations and Business Disposition—Sale of Textile Effects Business.”

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Table of Contents

2. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

There were no accounting pronouncements that we adopted during the three months ended March 31, 2023. Recently issued accounting pronouncements that become effective subsequent to March 31, 2023 either will not have a material impact on us or are not applicable to us.

3. DISCONTINUED OPERATIONS AND BUSINESS DISPOSITION

SaLE of tEXTILE eFFECTS bUSINESS

On February 28, 2023, we completed the sale of our Textile Effects Business to Archroma, a portfolio company of SK Capital Partners (“Archroma”), for a purchase price of $593 million, which includes estimated adjustments to the purchase price for working capital plus the assumption of underfunded pension liabilities. The final purchase price is subject to customary post-closing adjustments. Upon the completion of the sale, we received net proceeds of $530 million, determined as the preliminary purchase price less $5 million for certain costs paid by Archroma on our behalf, $30 million of estimated net working capital adjustments and $28 million of cash that will be reimbursed to us as part of the final post-closing adjustments anticipated in 2023. In connection with the sale, we recognized a pre-tax gain of $153 million in the first quarter of 2023. Through the first quarter of 2023, we have paid cash taxes of approximately $12 million, and we expect to pay additional cash taxes of approximately $30 million. Certain amounts for prior periods have been recast to present the results of operations of our Textile Effects Business as discontinued operations.

The following table reconciles the carrying amounts of major classes of assets and liabilities of discontinued operations to total assets and liabilities of discontinued operations that are classified as held for sale in our condensed consolidated balance sheets (dollars in millions):

	December 31,
	2022
Carrying amounts of major classes of assets held for sale:
Accounts receivable	$	133
Inventories		151
Other current assets		11
Property, plant and equipment, net		134
Deferred income taxes		13
Operating lease right-of-use assets		15
Other noncurrent assets		15
Total current assets held for sale(1)	$	472
Carrying amounts of major classes of liabilities held for sale:
Accounts payable	$	63
Accrued liabilities		47
Current operating lease liabilities		2
Noncurrent operating lease liabilities		17
Other noncurrent liabilities		65
Total current liabilities held for sale(1)	$	194

(1)	Total assets and liabilities held for sale as of December 31, 2022 are classified as current because we completed the sale of our Textile Effects Business on February 28, 2023.

Table of Contents

The following table reconciles major line items constituting pretax income of discontinued operations to after-tax income of discontinued operations, primarily related to our Textile Effects Business, as presented in our condensed consolidated statements of operations (dollars in millions):

	*Three months*
	*ended*
	*March 31,*
	*2023*			*2022*
Major line items constituting pretax income of discontinued operations:
Trade sales, services and fees, net	$	88		$	197
Cost of goods sold		69			147
Gain on sale of our Textile Effects Business		153			—
Other expense items, net		35			27
Income from discontinued operations before income taxes		137			23
Income tax expense		(15	)		(5	)
Net income attributable to discontinued operations	$	122		$	18

SaLE of Venator InterEST

On December 23, 2020, we completed the sale of approximately 42.4 million ordinary shares of Venator Materials PLC (“Venator”). Concurrent with the sale of ordinary shares, we entered into an option agreement, pursuant to which we granted an option to funds advised by SK Capital Partners, LP to purchase the remaining approximate 9.7 million ordinary shares we hold in Venator at $2.15 per share. The option will expire on June 23, 2023 and will not be exercisable so long as such exercise would result in a default or an “Event of Default” under Venator’s Term Loan Credit Agreement and Revolving Credit Agreement. We record this option at fair value with changes in fair value reported in earnings. We account for our remaining ownership interest in Venator as an investment in equity securities that are marked to fair value with changes in fair value reported in earnings. For the three months ended March 31, 2023 and 2022, we recorded net losses of $1 million and $2 million, respectively, to record our investment in Venator and related option at fair value. These net losses were recorded in “Fair value adjustments to Venator investment, net” in our condensed consolidated statements of operations.

4. INVENTORIES

We state our inventories at the lower of cost or market, with cost determined using average cost, last-in first-out (“LIFO”) and first-in first-out methods for different components of inventory. Inventories consisted of the following (dollars in millions):

	*March 31,*			*December 31,*
	*2023*			*2022*
Raw materials and supplies	$	238		$	241
Work in progress		43			40
Finished goods		809			758
Total		1,090			1,039
LIFO reserves		(42	)		(44	)
Net inventories	$	1,048		$	995

For both March 31, 2023 and December 31, 2022, approximately 8% of inventories were recorded using the LIFO cost method.

Table of Contents

5. VARIABLE INTEREST ENTITIES

We evaluate our investments and transactions to identify variable interest entities for which we are the primary beneficiary. We hold a variable interest in the following joint ventures for which we are the primary beneficiary:

●

Rubicon LLC is our 50%-owned joint venture with Lanxess that manufactures products for our Polyurethanes and Performance Products segments.

●

Arabian Amines Company (“AAC”) is our 50%-owned joint venture with Zamil group that manufactures products for our Performance Products segment.

During the three months ended March 31, 2023, there were no changes in our variable interest entities.

Creditors of our variable interest entities have no recourse to our general credit. See “Note 7. Debt—Direct and Subsidiary Debt.” As the primary beneficiary of these variable interest entities at March 31, 2023, the joint ventures’ assets, liabilities and results of operations are included in our condensed consolidated financial statements.

The following table summarizes the carrying amounts of our variable interest entities’ assets and liabilities included in our condensed consolidated balance sheet as of March 31, 2023 and our consolidated balance sheet as of December 31, 2022 (dollars in millions):

	*March 31,*		*December 31,*
	*2023*		*2022*
Current assets	$	77	$	73
Property, plant and equipment, net		147		149
Operating lease right-of-use assets		28		28
Other noncurrent assets		141		140
Deferred income taxes		13		13
Total assets	$	406	$	403
Current liabilities	$	129	$	144
Long-term debt		24		26
Noncurrent operating lease liabilities		18		19
Other noncurrent liabilities		24		25
Total liabilities	$	195	$	214

The revenues, income from continuing operations before income taxes and net cash provided by operating activities for our variable interest entities for the three months ended March 31, 2023 and 2022 are as follows (dollars in millions):

	*Three months*
	*ended*
	*March 31,*
	*2023*		*2022*
Revenues	$	—	$	—
Income from continuing operations before income taxes		15		5
Net cash provided by operating activities		25		8

Table of Contents

6. RESTRUCTURING, IMPAIRMENT AND PLANT CLOSING COSTS

As of March 31, 2023 and December 31, 2022, accrued restructuring costs by type of cost consisted of the following (dollars in millions):

	*Workforce reductions*			*Other restructuring costs*			*Total*
Accrued liabilities as of January 1, 2023	$	76		$	—		$	76
(Credits) charges		(10	)		3			(7	)
Payments		(17	)		(4	)		(21	)
Accrued liabilities as of March 31, 2023	$	49		$	(1	)	$	48

Details with respect to our reserves for restructuring, impairment and plant closing costs by segment are provided below (dollars in millions):

				*Performance*		*Advanced*			*Corporate*
	*Polyurethanes*			*Products*		*Materials*			*and other*			*Total*
Accrued liabilities as of January 1, 2023	$	24		$	5	$	10		$	37		$	76
(Credits) charges		(4	)		1		2			(6	)		(7	)
Payments		(6	)		—		(4	)		(11	)		(21	)
Accrued liabilities as of March 31, 2023	$	14		$	6	$	8		$	20		$	48

Current portion of restructuring reserves	$	14		$	6	$	8		$	20		$	48
Long-term portion of restructuring reserves		—			—		—			—			—

Details with respect to cash and noncash restructuring (credits) charges from continuing operations for the three months ended March 31, 2023 and 2022 are provided below (dollars in millions):

	*Three months*
	*ended*
	*March 31,*
	*2023*			*2022*
Cash credits	$	(7	)	$	—
Noncash charges:
Other noncash charges		—			—
Total restructuring, impairment and plant closing credits	$	(7	)	$	—

Table of Contents

Restructuring Activities

Beginning in the fourth quarter of 2022, we implemented a restructuring program to further realign our cost structure with additional restructuring in Europe. This program is associated with all of our segments and includes exiting and consolidating certain facilities, workforce relocation to lower cost locations and further personnel rationalization. During the first quarter of 2023, we evaluated current developments of this program and related anticipated cash costs, and we recorded a net restructuring credit of approximately $8 million for the three months ended March 31, 2023, primarily to adjust restructuring reserves that are no longer required for certain workforce reductions. We expect to record further restructuring expenses of approximately $7 million through the end of 2023.

Beginning in the first quarter of 2021, our Corporate function implemented a restructuring program to optimize our global approach to leveraging shared services capabilities. During the second quarter of 2022, this program was further expanded to include additional geographies. During the first quarter of 2023, we evaluated current developments of this program and related anticipated cash costs, and we recorded a net restructuring credit of approximately $5 million for the three months ended March 31, 2023, primarily to adjust restructuring reserves that are no longer required for certain workforce reductions. There were no significant restructuring costs incurred during the three months ended March 31, 2022. We expect to record further restructuring expenses of approximately $1 million through the end of 2023.

Beginning in the third quarter of 2020, our Polyurethanes segment implemented a restructuring program to optimize its downstream footprint. During the second quarter of 2022, this optimization program was further expanded to include the entire Polyurethanes business. In connection with this restructuring program, we recorded net restructuring expense of approximately $2 million in the three months ended March 31, 2023, primarily related to workforce reductions. There were no significant restructuring costs incurred during the three months ended March 31, 2022. We expect to record further restructuring expenses of approximately $1 million through the end of 2023.

Beginning in the second quarter of 2020, our Advanced Materials segment implemented restructuring programs in connection with the CVC Thermoset Specialties Acquisition, the alignment of the segment’s commercial organization and optimization of the segment’s manufacturing processes. In connection with these restructuring programs, we recorded net restructuring expense of approximately $2 million in the three months ended March 31, 2023, primarily related to a site closure. There were no significant restructuring costs incurred during the three months ended March 31, 2022. We expect to record further restructuring expenses of approximately $1 million through the end of 2023.

7. DEBT

Our outstanding debt, net of debt issuance costs, consisted of the following (dollars in millions):

	*March 31,*		*December 31,*
	*2023*		*2022*
Senior Credit Facilities:
Revolving facility	$	—	$	55
Amounts outstanding under A/R programs		—		166
Senior notes		1,462		1,455
Variable interest entities		33		35
Other		25		26
Total debt	$	1,520	$	1,737
Current portion of debt	$	11	$	66
Long-term portion of debt		1,509		1,671
Total debt	$	1,520	$	1,737

Direct and Subsidiary Debt

Substantially all of our debt, including the facilities described below, has been incurred by our subsidiaries (primarily Huntsman International). Huntsman Corporation is not a guarantor of such subsidiary debt.

Certain of our subsidiaries have third-party debt agreements that contain certain restrictions with regard to dividends, distributions, loans or advances. In certain circumstances, the consent of a third party would be required prior to the transfer of any cash or assets from these subsidiaries to us.

Debt Issuance Costs

We record debt issuance costs related to a debt liability on the balance sheets as a reduction to the face amount of that debt liability. As of both March 31, 2023 and December 31, 2022, the amount of debt issuance costs directly reducing the debt liability was $8 million. We amortize debt issuance costs using either a straight line or effective interest method, depending on the debt agreement, and record them as interest expense.

Table of Contents

Revolving Credit Facility

On May 20, 2022, Huntsman International entered into a new $1.2 billion senior unsecured revolving credit facility (the “2022 Revolving Credit Facility”). Borrowings will bear interest at the rates specified in the credit agreement governing the 2022 Revolving Credit Facility, which will vary based on the type of loan and Huntsman International’s debt ratings. Under the credit agreement, the interest rate margin and the commitment fee rates are also subject to adjustments based on the Company’s performance on specified sustainability target thresholds with respect to annual percentage reduction in operational greenhouse gas emissions intensity and annual percentage reduction in water consumption intensity. Unless previously terminated in accordance with its terms, the credit agreement will mature in May 2027. Huntsman International may increase the 2022 Revolving Credit Facility commitments up to an additional $500 million, subject to the satisfaction of certain conditions.

The following table presents certain amounts under our 2022 Revolving Credit Facility as of March 31, 2023 (monetary amounts in millions):

Unamortized

discounts and

Committed

Principal

debt issuance

Carrying

Facility

amount

outstanding

costs

value

Interest rate(2)

Maturity

2022 Revolving Credit Facility

1,200

—

(1)

—

(1)

—

(1)

Term Secured Overnight Financing Rate (“SOFR”) plus 1.475%

May 2027

(1)	On March 31, 2023, we had an additional $13 million (U.S. dollar equivalents) of letters of credit and bank guarantees issued and outstanding under our 2022 Revolving Credit Facility.

(2)	Interest rates on borrowings under the 2022 Revolving Credit Facility vary based on the type of loan and Huntsman International’s debt ratings. The representative interest rate for U.S. dollar borrowings as of March 31, 2023 was 1.475% above term SOFR.

A/R Programs

Our U.S. accounts receivable securitization program (“U.S. A/R Programs”) and our European accounts receivable securitization program (“EU A/R Program” and collectively with the U.S. A/R Program, “A/R Programs”) are structured so that we transfer certain of our trade receivables to the U.S. special purpose entity (“U.S. SPE”) and the European special purpose entity (“EU SPE”) in transactions intended to be true sales or true contributions. The receivables collateralize debt incurred by the U.S. SPE and the EU SPE.

On July 1, 2021, we entered into amendments to our A/R Programs that, among other things, extended the respective scheduled termination dates of our A/R Programs from April 2022 to July 2024.

Information regarding our A/R Programs as of March 31, 2023 was as follows (monetary amounts in millions):

Maximum funding

Amount

Facility

Maturity

availability(1)

outstanding

Interest rate(2)

U.S. A/R Program

July 2024

150

—

(3)

Applicable rate plus 0.90%

EU A/R Program

July 2024

€

100

€

—

Applicable rate plus 1.30%

(or approximately $109)

(1)

The amount of actual availability under our A/R Programs may be lower based on the level of eligible receivables sold, changes in the credit ratings of our customers, customer concentration levels and certain characteristics of the accounts receivable being transferred, as defined in the applicable agreements.

(2)

The applicable rate for our U.S. A/R Program is defined by the lender as USD LIBOR. The applicable rate for our EU A/R Program is either USD LIBOR, EURIBOR or SONIA (Sterling Overnight Interbank Average Rate). In anticipation of the transition away from USD LIBOR, the amendments we made in July 2021 to our A/R Programs incorporated replacement rates for the USD LIBOR.

(3)	As of March 31, 2023, we had approximately $8 million (U.S. dollar equivalents) of letters of credit issued and outstanding under our U.S. A/R Program.

As of March 31, 2023 and December 31, 2022, $306 million and $272 million, respectively, of accounts receivable were pledged as collateral under our A/R Programs.

Senior Notes

Our senior notes consisted of the following (monetary amounts in millions):

Unamortized

premiums,

discounts

and debt

Notes

Maturity

Interest rate

Amount outstanding

issuance costs

2025 Senior Notes

April 2025

4.25

€300 (€299 carrying value $(325))

2029 Senior Notes

February 2029

4.50

$750 ($740 carrying value)

2031 Senior Notes

June 2031

2.95

$400 ($397 carrying value)

Table of Contents

Variable Interest Entity Debt

As of March 31, 2023, AAC, our consolidated 50%-owned joint venture, had $33 million outstanding under its loan commitments and debt financing arrangements. As of March 31, 2023, we have $9 million classified as current debt and $24 million as long-term debt on our condensed consolidated balance sheets. We do not guarantee these loan commitments, and AAC is not a guarantor of any of our other debt obligations.

Compliance with Covenants

We believe that we are in compliance with the covenants contained in the agreements governing our material debt instruments, including our 2022 Revolving Credit Facility, our A/R Programs and our senior notes.

8. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

We are exposed to market risks, such as changes in interest rates, foreign exchange rates and commodity prices. From time to time, we enter into transactions, including transactions involving derivative instruments, to manage certain of these exposures. We also hedge our net investment in certain European operations.

Our revenues and expenses are denominated in various foreign currencies, and our cash flows and earnings are thus subject to fluctuations due to exchange rate variations. From time to time, we may enter into foreign currency derivative instruments to minimize the short-term impact of movements in foreign currency rates. Where practicable, we generally net multicurrency cash balances among our subsidiaries to help reduce exposure to foreign currency exchange rates. Certain other exposures may be managed from time to time through financial market transactions, principally through the purchase of spot or forward foreign exchange contracts (generally with maturities of one year or less). We do not hedge our foreign currency exposures in a manner that would eliminate the effect of changes in exchange rates on our cash flows and earnings. As of March 31, 2023, we had approximately $387 million in notional amount (in U.S. dollar equivalents) outstanding in forward foreign currency contracts related to continuing operations.

From time to time, we may purchase interest rate swaps and/or other derivative instruments to reduce the impact of changes in interest rates on our floating-rate exposures. Under interest rate swaps, we agree with other parties to exchange, at specified intervals, the difference between fixed-rate and floating-rate interest amounts calculated by reference to an agreed notional principal amount.

We review our non-U.S. dollar denominated debt and derivative instruments to determine the appropriate amounts designated as hedges. As of March 31, 2023, we have designated approximately €175 million (approximately $190 million) of euro-denominated debt as a hedge of our net investment. For the three months ended March 31, 2023 and 2022, the amounts recognized on the hedge of our net investment were a loss of $4 million and a gain of $3 million, respectively, and were recorded in other comprehensive (loss) income in our condensed consolidated statements of comprehensive income.

9. FAIR VALUE

The fair values of financial instruments were as follows (dollars in millions):

	*March 31, 2023*						*December 31, 2022*
	*Carrying*			*Estimated*			*Carrying*			*Estimated*
	*value*			*fair value*			*value*			*fair value*
Non-qualified employee benefit plan investments	$	14		$	14		$	15		$	15
Investment in Venator		4			4			5			5
Option agreement for remaining Venator shares		—			—			—			—
Long-term debt (including current portion)		(1,520	)		(1,418	)		(1,737	)		(1,578	)

The carrying amounts reported in the balance sheets of cash and cash equivalents, accounts receivable and accounts payable approximate fair value because of the immediate or short-term maturity of these financial instruments. The fair values of non-qualified employee benefit plan investments are obtained through market observable pricing using prevailing market prices (Level 1). The estimated fair values of our long-term debt are based on quoted market prices for the identical liability when traded in an active market (Level 1). Our investment in Venator is marked to fair value, which is obtained through market observable pricing using prevailing market prices (Level 1). Additionally, the estimated fair value of the option agreement related to the remaining ordinary shares we hold in Venator, which rounds to nil as of both March 31, 2023 and December 31, 2022, is based on a valuation technique using market observable inputs (Level 2). See “Note 3. Discontinued Operations and Business Disposition—Sale of Venator Interest.” The fair value estimates presented herein are based on pertinent information available to management as of March 31, 2023 and December 31, 2022. Although we are not aware of any factors that would significantly affect the estimated fair value amounts, such amounts have not been comprehensively revalued for purposes of these financial statements since March 31, 2023, and current estimates of fair value may differ significantly from the amounts presented herein.

During the three months ended March 31, 2023, we held no instruments measured at fair value on a recurring basis using significant unobservable inputs (Level 3), and there were no gains or losses (realized and unrealized) included in our earnings for instruments categorized as Level 3 within the fair value hierarchy.

Table of Contents

10. REVENUE RECOGNITION

The following tables disaggregate our revenue from continuing operations by major source for the three months ended March 31, 2023 and 2022 (dollars in millions):

			*Performance*		*Advanced*		*Corporate and*
2023	*Polyurethanes*		*Products*		*Materials*		*eliminations*			*Total*
Primary geographic markets(1)
U.S. and Canada	$	386	$	157	$	89	$	(3	)	$	629
Europe		272		74		116		(4	)		458
Asia Pacific		258		79		62		(1	)		398
Rest of world		75		24		22		—			121
	$	991	$	334	$	289	$	(8	)	$	1,606

Major product groupings
MDI urethanes	$	991								$	991
Differentiated			$	334							334
Specialty					$	268					268
Other						21					21
Eliminations							$	(8	)		(8	)
	$	991	$	334	$	289	$	(8	)	$	1,606

			*Performance*		*Advanced*		*Corporate and*
2022	*Polyurethanes*		*Products*		*Materials*		*eliminations*			*Total*
Primary geographic markets(1)
U.S. and Canada	$	560	$	205	$	106	$	(3	)	$	868
Europe		355		120		128		(4	)		599
Asia Pacific		360		124		71		(1	)		554
Rest of world		111		31		30		(1	)		171
	$	1,386	$	480	$	335	$	(9	)	$	2,192

Major product groupings
MDI urethanes	$	1,386								$	1,386
Differentiated			$	480							480
Specialty					$	306					306
Other						29					29
Eliminations							$	(9	)		(9	)
	$	1,386	$	480	$	335	$	(9	)	$	2,192

(1)	Geographic information for revenues is based upon countries into which product is sold.

Table of Contents

11. EMPLOYEE BENEFIT PLANS

Components of the net periodic benefit (credit) cost from continuing operations for the three months ended March 31, 2023 and 2022 were as follows (dollars in millions):

Huntsman Corporation

							*Other postretirement*
	*Defined benefit plans*						*benefit plans*
	*Three months*						*Three months*
	*ended*						*ended*
	*March 31,*						*March 31,*
	*2023*			*2022*			*2023*			*2022*
Service cost	$	6		$	11		$	—		$	—
Interest cost		23			13			1			—
Expected return on assets		(31	)		(38	)		—			—
Amortization of prior service benefit		(1	)		(1	)		(1	)		(1	)
Amortization of actuarial loss		8			12			—			1
Net periodic benefit cost (credit)	$	5		$	(3	)	$	—		$	—

Huntsman International

							*Other postretirement*
	*Defined benefit plans*						*benefit plans*
	*Three months*						*Three months*
	*ended*						*ended*
	*March 31,*						*March 31,*
	*2023*			*2022*			*2023*			*2022*
Service cost	$	6		$	11		$	—		$	—
Interest cost		23			13			1			—
Expected return on assets		(31	)		(38	)		—			—
Amortization of prior service benefit		(1	)		(1	)		(1	)		(1	)
Amortization of actuarial loss		8			12			—			1
Net periodic benefit cost (credit)	$	5		$	(3	)	$	—		$	—

During both of the three months ended March 31, 2023 and 2022, we made contributions to our pension and other postretirement benefit plans related to continuing operations of $11 million. During the remainder of 2023, we expect to contribute an additional amount of approximately $28 million to these plans.

Table of Contents

12. HUNTSMAN CORPORATION STOCKHOLDERS’ EQUITY

Share Repurchase Program

On October 26, 2021, our Board of Directors approved a share repurchase program of $1 billion. On March 25, 2022, our Board of Directors increased the authorization of our share repurchase program from $1 billion to $2 billion. The share repurchase program is supported by our free cash flow generation. Repurchases may be made in the open market, including through accelerated share repurchase programs, or in privately negotiated transactions, and repurchases may be commenced or suspended from time to time without prior notice. Shares of common stock acquired through the repurchase program are held in treasury at cost. During the three months ended March 31, 2023, we repurchased 3,472,020 shares of our common stock for approximately $101 million, including commissions, under this share repurchase program. From April 1, 2023 through April 25, 2023, we repurchased an additional 588,282 shares of our common stock for approximately $16 million.

Dividends on Common Stock

During the quarters ended March 31, 2023 and March 31, 2022, we declared dividends of $44 million and $45 million, respectively, or $0.2375 and $0.2125 per share, respectively, to common stockholders.

13. ACCUMULATED OTHER COMPREHENSIVE LOSS

The components of other comprehensive (loss) income and changes in accumulated other comprehensive loss by component were as follows (dollars in millions):

Huntsman Corporation

				*Pension*			*Other*
	*Foreign*			*and other*			*comprehensive*								*Amounts*			*Amounts*
	*currency*			*postretirement*			*income of*								*attributable to*			*attributable to*
	*translation*			*benefits*			*unconsolidated*								*noncontrolling*			*Huntsman*
	*adjustments(a)*			*adjustments(b)*			*affiliates*		*Other, net*			*Total*			*interests*			*Corporation*
Beginning balance, January 1, 2023	$	(648	)	$	(652	)	$	2	$	5		$	(1,293	)	$	25		$	(1,268	)
Other comprehensive income (loss) before reclassifications, gross		27			(24	)		—		(1	)		2			(2	)		—
Tax impact		—			2			—		—			2			—			2
Amounts reclassified from accumulated other comprehensive loss, gross(c)		28			72			—		—			100			—			100
Tax impact		(1	)		24			—		—			23			—			23
Net current-period other comprehensive income (loss)		54			74			—		(1	)		127			(2	)		125
Ending balance, March 31, 2023	$	(594	)	$	(578	)	$	2	$	4		$	(1,166	)	$	23		$	(1,143	)

(a)	Amounts are net of tax of $56 million and $55 million as of March 31, 2023 and January 1, 2023, respectively.

(b)	Amounts are net of tax of $57 million and $31 million as of March 31, 2023 and January 1, 2023, respectively.

(c)	See table below for details about these reclassifications.

				*Pension*			*Other*
	*Foreign*			*and other*			*comprehensive*								*Amounts*		*Amounts*
	*currency*			*postretirement*			*income of*								*attributable to*		*attributable to*
	*translation*			*benefits*			*unconsolidated*								*noncontrolling*		*Huntsman*
	*adjustments(a)*			*adjustments(b)*			*affiliates*		*Other, net*			*Total*			*interests*		*Corporation*
Beginning balance, January 1, 2022	$	(420	)	$	(810	)	$	8	$	6		$	(1,216	)	$	13	$	(1,203	)
Other comprehensive loss before reclassifications, gross		(20	)		—			—		(1	)		(21	)		1		(20	)
Tax impact		—			—			—		—			—			—		—
Amounts reclassified from accumulated other comprehensive loss, gross(c)		—			13			—		—			13			—		13
Tax impact		—			(4	)		—		—			(4	)		—		(4	)
Net current-period other comprehensive (loss) income		(20	)		9			—		(1	)		(12	)		1		(11	)
Ending balance, March 31, 2022	$	(440	)	$	(801	)	$	8	$	5		$	(1,228	)	$	14	$	(1,214	)

(a)	Amounts are net of tax of $56 million for both March 31, 2022 and January 1, 2022.

(b)	Amounts are net of tax of $77 million and $81 million as of March 31, 2022 and January 1, 2022, respectively.

(c)	See table below for details about these reclassifications.

Table of Contents

	*Three Months Ended March 31,*
	*2023*			*2022*
	*Amounts reclassified*			*Amounts reclassified*				*Affected line item in*
	*from accumulated*			*from accumulated*				*the statement*
Details about accumulated other	*other*			*other*				*where net income*
comprehensive loss components(a):	*comprehensive loss*			*comprehensive loss*				*is presented*
Amortization of pension and other postretirement benefits:
Prior service credit	$	(2	)	$	(2	)	(b)(c)	Other income, net
Actuarial loss		8			15		(b)(c)	Other income, net
Curtailment gains		(1	)		—		(d)	Other income, net
Settlement losses		67			—		(d)	Other income, net
		72			13			Total before tax
		24			(4	)		Income tax expense
Total reclassifications for the period	$	96		$	9			Net of tax

(a)	Pension and other postretirement benefits amounts in parentheses indicate credits on our condensed consolidated statements of operations.

(b)	These accumulated other comprehensive loss components are included in the computation of net periodic pension costs. See “Note 11. Employee Benefit Plans.”

(c)	Amounts include approximately $1 million of actuarial losses and prior service credits related to discontinued operations for both of the three months ended March 31, 2023 and 2022.

(d)	In connection with the sale of our Textile Effects Business, we recognized $67 million of pension settlement losses and $1 million of pension curtailment gains for the three months ended March 31, 2023.

Huntsman International

				*Pension*			*Other*
	*Foreign*			*and other*			*comprehensive*							*Amounts*			*Amounts*
	*currency*			*postretirement*			*income of*							*attributable to*			*attributable to*
	*translation*			*benefits*			*unconsolidated*							*noncontrolling*			*Huntsman*
	*adjustments(a)*			*adjustments(b)*			*affiliates*		*Other, net*		*Total*			*interests*			*International*
Beginning balance, January 1, 2023	$	(653	)	$	(628	)	$	2	$	1	$	(1,278	)	$	25		$	(1,253	)
Other comprehensive income (loss) before reclassifications, gross		27			(24	)		—		—		3			(2	)		1
Tax impact		—			2			—		—		2			—			2
Amounts reclassified from accumulated other comprehensive loss, gross(c)		28			72			—		—		100			—			100
Tax impact		(1	)		24			—		—		23			—			23
Net current-period other comprehensive income (loss)		54			74			—		—		128			(2	)		126
Ending balance, March 31, 2023	$	(599	)	$	(554	)	$	2	$	1	$	(1,150	)	$	23		$	(1,127	)

(a)	Amounts are net of tax of $43 million and $42 million as of March 31, 2023 and January 1, 2023, respectively.

(b)	Amounts are net of tax of $81 million and $55 million as of March 31, 2023 and January 1, 2023, respectively.

(c)	See table below for details about these reclassifications.

Table of Contents

				*Pension*			*Other*
	*Foreign*			*and other*			*comprehensive*								*Amounts*		*Amounts*
	*currency*			*postretirement*			*income of*								*attributable to*		*attributable to*
	*translation*			*benefits*			*unconsolidated*								*noncontrolling*		*Huntsman*
	*adjustments(a)*			*adjustments(b)*			*affiliates*		*Other, net*			*Total*			*interests*		*International*
Beginning balance, January 1, 2022	$	(424	)	$	(786	)	$	8	$	2		$	(1,200	)	$	13	$	(1,187	)
Other comprehensive loss before reclassifications, gross		(20	)		—			—		(1	)		(21	)		1		(20	)
Tax impact		—			—			—		—			—			—		—
Amounts reclassified from accumulated other comprehensive loss, gross(c)		—			13			—		—			13			—		13
Tax impact		—			(4	)		—		—			(4	)		—		(4	)
Net current-period other comprehensive (loss) income		(20	)		9			—		(1	)		(12	)		1		(11	)
Ending balance, March 31, 2022	$	(444	)	$	(777	)	$	8	$	1		$	(1,212	)	$	14	$	(1,198	)

(a)	Amounts are net of tax of $43 million for both March 31, 2022 and January 1, 2022.

(b)	Amounts are net of tax of $101 million and $105 million as of March 31, 2022 and January 1, 2022, respectively.

(c)	See table below for details about these reclassifications.

	*Three Months Ended March 31,*
	*2023*			*2022*
	*Amounts reclassified*			*Amounts reclassified*				*Affected line item in*
	*from accumulated*			*from accumulated*				*the statement*
Details about accumulated other	*other*			*other*				*where net income*
comprehensive loss components(a):	*comprehensive loss*			*comprehensive loss*				*is presented*
Amortization of pension and other postretirement benefits:
Prior service credit	$	(2	)	$	(2	)	(b)(c)	Other income, net
Actuarial loss		8			15		(b)(c)	Other income, net
Curtailment gains		(1	)		—		(d)	Other income, net
Settlement losses		67			—		(d)	Other income, net
		72			13			Total before tax
		24			(4	)		Income tax expense
Total reclassifications for the period	$	96		$	9			Net of tax

(a)	Pension and other postretirement benefits amounts in parentheses indicate credits on our condensed consolidated statements of operations.

(b)	These accumulated other comprehensive loss components are included in the computation of net periodic pension costs. See “Note 11. Employee Benefit Plans.”

(c)	Amounts include approximately $1 million of actuarial losses and prior service credits related to discontinued operations for both of the three months ended March 31, 2023 and 2022.

(d)	In connection with the sale of our Textile Effects Business, we recognized $67 million of pension settlement losses and $1 million of pension curtailment gains for the three months ended March 31, 2023.

Table of Contents

14. COMMITMENTS AND CONTINGENCIES

Legal Matters

On April 29, 2022, a New Orleans jury awarded us approximately $94 million in our long-running court battle against Praxair/Linde, one of the industrial gas suppliers to our Geismar, Louisiana MDI manufacturing site. The case was filed after Praxair refused to properly maintain its own Geismar facility and then repeatedly failed to supply our requirements for industrial gas needed to manufacture MDI under long-term supply contracts that expired in 2013. After adding mandatory pre-judgment and post-judgment interest to the award, we expect damages to exceed $125 million before deducting for taxes and legal fees. The award is subject to a pending appeal, and if affirmed, we expect to receive net proceeds of approximately $50 million to $60 million. We have not yet recognized the award in our condensed consolidated statements of operations and the timing of the resolution of this matter is unknown.

We are a party to various other proceedings instituted by private plaintiffs, governmental authorities and others arising under provisions of applicable laws, including various environmental, products liability and other laws. We do not believe that the outcome of any of these matters will have a material effect on our financial condition, results of operations or liquidity.

15. ENVIRONMENTAL, HEALTH AND SAFETY MATTERS

EHS Capital Expenditures

We may incur future costs for capital improvements and general compliance under environmental, health and safety (“EHS”) laws, including costs to acquire, maintain and repair pollution control equipment. For the three months ended March 31, 2023 and 2022, our capital expenditures from continuing operations for EHS matters totaled $6 million and $7 million, respectively. Because capital expenditures for these matters are subject to evolving regulatory requirements and depend, in part, on the timing, promulgation and enforcement of specific requirements, our capital expenditures for EHS matters have varied significantly from year to year and we cannot provide assurance that our recent expenditures are indicative of future amounts we may spend related to EHS and other applicable laws.

Environmental Reserves

We have accrued liabilities relating to anticipated environmental cleanup obligations, site reclamation and closure costs and known penalties. Liabilities are recorded when potential liabilities are either known or considered probable and can be reasonably estimated. Our liability estimates are calculated using present value techniques as appropriate and are based upon requirements placed upon us by regulators, available facts, existing technology and past experience. The environmental liabilities do not include amounts recorded as asset retirement obligations. We had accrued $5 million for environmental liabilities as of both March 31, 2023 and December 31, 2022. Of these amounts, $1 million was classified as accrued liabilities in our condensed consolidated balance sheets as of both March 31, 2023 and December 31, 2022 and $4 million was classified as other noncurrent liabilities in our condensed consolidated balance sheets as of both March 31, 2023 and December 31, 2022. In certain cases, our remediation liabilities may be payable over periods of up to 30 years. We may incur losses for environmental remediation in excess of the amounts accrued; however, we are not able to estimate the amount or range of such potential excess.

Environmental Matters

Under the Comprehensive Environmental Response, Compensation, and Liability Act (“CERCLA”) and similar state laws, a current or former owner or operator of real property in the U.S. may be liable for remediation costs regardless of whether the release or disposal of hazardous substances was in compliance with law at the time it occurred, and a current owner or operator may be liable regardless of whether it owned or operated the facility at the time of the release. Outside the U.S., analogous contaminated property laws can hold past owners and/or operators liable for remediation at former facilities. Currently, there are approximately six former facilities or third-party sites in the U.S. for which we have been notified of potential claims against us for cleanup liabilities, including, but not limited to, sites listed under CERCLA. Based on current information and past experiences at other CERCLA sites, we do not expect these third-party claims to have a material impact on our condensed consolidated financial statements.

Under the Resource Conservation and Recovery Act (“RCRA”) in the U.S. and similar state laws, we may be required to remediate contamination originating from our properties. Similar laws exist in a number of non-U.S. locations in which we currently operate, or previously operated, manufacturing facilities. Some of our manufacturing sites have an extended history of industrial chemical manufacturing and use, including on-site waste disposal. We are aware of soil, groundwater or surface contamination from past operations at some of our sites, and we may find contamination at other sites in the future. For example, our Geismar, Louisiana facility is the subject of ongoing remediation requirements imposed under RCRA.

North Maybe Canyon Mine Remediation

The North Maybe Canyon Mine site is a CERCLA site and involves a former phosphorous mine near Soda Springs, Idaho, which is believed to have been operated by several companies, including a predecessor company to us. In 2004, the U.S. Forest Service notified us that we are a CERCLA potentially responsible party (“PRP”) for contamination originating from the site. In February 2010, we and Wells Cargo (another PRP) agreed to conduct a Remedial Investigation/Feasibility Study of a portion of the site and are currently engaged in that process. At this time, we are unable to reasonably estimate our potential liabilities at this site.

Table of Contents

16. STOCK-BASED COMPENSATION PLANS

As of March 31, 2023, we had approximately 5 million shares remaining under the stock-based compensation plans available for grant. Option awards have a maximum contractual term of 10 years and generally must have an exercise price at least equal to the market price of our common stock on the date the option award is granted. Outstanding stock-based awards generally vest annually over a three-year period or in total at the end of a three-year period. Certain performance share unit awards vest in total at the end of a two-year period.

The compensation cost from continuing operations under the stock-based compensation plans for our Company and Huntsman International were as follows (dollars in millions):

	*Three months*
	*ended*
	*March 31,*
	*2023*		*2022*
Huntsman Corporation compensation cost	$	9	$	10
Huntsman International compensation cost		8		8

The total income tax benefit recognized in the condensed consolidated statements of operations for us and Huntsman International for stock-based compensation arrangements was $1 million and $4 million for the three months ended March 31, 2023 and 2022, respectively.

Stock Options

The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses the assumptions noted in the following table. Expected volatilities are based on the historical volatility of our common stock through the grant date. The expected term of options granted was estimated based on the contractual term of the instruments and employees’ expected exercise and post-vesting employment termination behavior. The risk-free rate for periods within the contractual life of the option was based on the U.S. Treasury yield curve in effect at the time of grant. The assumptions noted below represent the weighted average of the assumptions utilized for stock options granted during the periods.

During each of the three months ended March 31, 2023 and 2022, no stock options were granted.

A summary of stock option activity under the stock-based compensation plans as of March 31, 2023 and changes during the three months then ended is presented below:

						*Weighted*
				*Weighted*		*average*
				*average*		*remaining*		*Aggregate*
				*exercise*		*contractual*		*intrinsic*
Option awards	*Shares*			*price*		*term*		*value*
	(in thousands)					(years)		(in millions)
Outstanding at January 1, 2023		3,413		$	21.93
Exercised		(45	)		21.79
Forfeited		(10	)		29.72
Outstanding at March 31, 2023		3,358			21.91		4.3	$	20
Exercisable at March 31, 2023		3,270			21.76		4.2		20

Table of Contents

As of March 31, 2023, there was approximately $1 million of total unrecognized compensation cost related to nonvested stock option arrangements granted under the stock-based compensation plans. That cost is expected to be recognized over a weighted-average period of approximately 0.9 years.

The total intrinsic value of stock options exercised during the three months ended March 31, 2023 and 2022 was approximately nil and $11 million, respectively. Cash received from stock options exercised during the three months ended March 31, 2023 and 2022 was approximately nil and $5 million, respectively. The cash tax benefit from stock options exercised during the three months ended March 31, 2023 and 2022 was approximately nil and $2 million, respectively.

Nonvested Shares

Nonvested shares granted under the stock-based compensation plans consist of restricted stock and performance share unit awards, which are accounted for as equity awards, and phantom stock, which is accounted for as a liability award because it can be settled in either stock or cash. The fair value of each restricted stock and phantom stock award is estimated to be the closing stock price of Huntsman’s stock on the date of grant.

We grant two types of performance share unit awards. For one type of performance share unit award, the performance criteria are total stockholder return of our common stock relative to the total stockholder return of a specified industry peer group for the three-year performance periods. The fair value of each performance share unit award is estimated using a Monte Carlo simulation model that uses various assumptions, including an expected volatility rate and a risk-free interest rate. For the three months ended March 31, 2023 and 2022, the weighted-average expected volatility rate was 37.6% and 43.5%, respectively, and the weighted average risk-free interest rate was 4.38% and 1.67%, respectively. For the performance share unit awards granted during the three months ended March 31, 2023 and 2022, the number of shares earned varies based upon the Company achieving certain performance criteria over a three-year performance period.

During the first quarter of 2022, we granted a second type of performance share unit award, which also includes a market condition. The performance criteria are our corporate free cash flow achieved relative to targets set by management, modified for the total stockholder return of our common stock relative to the total stockholder return of a specified industry peer group for the two-year performance period. The fair value of each performance share unit award is estimated using a Monte Carlo simulation model that uses various assumptions, including an expected volatility rate and a risk-free interest rate. For the three months ended March 31, 2022, the weighted-average expected volatility rate was 37.9% and the weighted average risk-free interest rate was 1.43%. For the performance share unit awards granted during the three months ended March 31, 2022, the number of shares earned varies based upon the Company achieving certain performance criteria over a two-year performance period. No performance share unit awards of this type were granted during the three months ended March 31, 2023.

A summary of the status of our nonvested shares as of March 31, 2023 and changes during the three months then ended is presented below:

	*Equity awards*						*Liability awards*
					*Weighted*					*Weighted*
					*average*					*average*
					*grant-date*					*grant-date*
	*Shares*				*fair value*		*Shares*			*fair value*
	(in thousands)						(in thousands)
Nonvested at January 1, 2023		1,802			$	35.15		257		$	31.61
Granted		945				36.54		114			30.83
Vested		(711	)	⁽¹⁾⁽²⁾		27.28		(165	)		29.51
Forfeited		(22	)			37.53		(5	)		33.07
Nonvested at March 31, 2023		2,014				38.55		201			32.85

(1)

As of March 31, 2023, a total of 115,685 restricted stock units were vested but not yet issued, of which 9,400 vested during the three months ended March 31, 2023. These shares have not been reflected as vested shares in this table because, in accordance with the restricted stock unit agreements, shares of common stock are not issued for vested restricted stock units until termination of employment.

(2)

A total of 264,624 performance share unit awards are reflected in the vested shares in this table, which represents the target number of performance share unit awards for this grant and were included in the balance at December 31, 2022. During the three months ended March 31, 2023, an additional 132,314 performance share unit awards with a grant date fair value of $22.85 were issued due to the target performance criteria being exceeded.

As of March 31, 2023, there was approximately $52 million of total unrecognized compensation cost related to nonvested share compensation arrangements granted under the stock-based compensation plans. That cost is expected to be recognized over a weighted-average period of approximately 2.3 years. The value of share awards that vested during the three months ended March 31, 2023 and 2022 was approximately $28 million and $31 million, respectively.

Table of Contents

17. INCOME TAXES

We use the asset and liability method of accounting for income taxes. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial and tax reporting purposes. We evaluate deferred tax assets to determine whether it is more likely than not that they will be realized. Valuation allowances are reviewed on an individual tax jurisdiction basis to analyze whether there is sufficient positive or negative evidence to support a change in judgment about the realizability of the related deferred tax assets. These conclusions require significant judgment. In evaluating the objective evidence that historical results provide, we consider the cyclicality of our businesses and cumulative income or losses during the applicable period. Cumulative losses incurred over the applicable period limits our ability to consider other subjective evidence such as our projections for the future. Changes in expected future income in applicable jurisdictions could affect the realization of deferred tax assets in those jurisdictions.

Huntsman Corporation

We recorded income tax expense from continuing operations of $11 million and $60 million for the three months ended March 31, 2023 and 2022, respectively. Our tax expense is significantly affected by the mix of income and losses in the tax jurisdictions in which we operate, as impacted by the presence of valuation allowances in certain tax jurisdictions.

Huntsman International

Huntsman International recorded income tax expense from continuing operations of $11 million and $60 million for the three months ended March 31, 2023 and 2022, respectively. Our tax expense is significantly affected by the mix of income and losses in the tax jurisdictions in which we operate, as impacted by the presence of valuation allowances in certain tax jurisdictions.

18. EARNINGS PER SHARE

Basic income per share excludes dilution and is computed by dividing net income attributable to Huntsman Corporation by the weighted average number of shares outstanding during the period. Diluted income per share reflects all potential dilutive common shares outstanding during the period and is computed by dividing net income attributable to Huntsman Corporation by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding as potential dilutive securities.

Basic and diluted income per share is determined using the following information (in millions):

	*Three months*
	*ended*
	*March 31,*
	*2023*		*2022*
Numerator:
Income from continuing operations attributable to Huntsman Corporation	$	31	$	205
Net income attributable to Huntsman Corporation	$	153	$	223

Denominator:
Weighted average shares outstanding		182.7		212.7
Dilutive shares:
Stock-based awards		1.7		2.7
Total weighted average shares outstanding, including dilutive shares		184.4		215.4

Additional stock-based awards of approximately 1.5 million and 0.4 million weighted average equivalent shares of stock were outstanding during the three months ended March 31, 2023 and 2022, respectively. However, these stock-based awards were not included in the computation of diluted income per share for the respective periods mentioned above because the effect would be anti-dilutive.

Table of Contents

19. OPERATING SEGMENT INFORMATION

We derive our revenues, earnings and cash flows from the manufacture and sale of a wide variety of diversified organic chemical products. We have three operating segments, which are also our reportable segments: Polyurethanes, Performance Products and Advanced Materials. We have organized our business and derived our operating segments around differences in product lines.

The major products of each reportable operating segment are as follows:

Segment		Products
Polyurethanes		MDI, polyols, TPU and other polyurethane-related products
Performance Products		Specialty amines, ethyleneamines, maleic anhydride and technology licenses
Advanced Materials		Technologically-advanced epoxy, phenoxy, acrylic, polyurethane and acrylonitrile-butadiene-based polymer formulations; high performance thermoset resins, curing agents, toughening agents, and carbon nanotubes additives

Sales between segments are generally recognized at external market prices and are eliminated in consolidation. We use adjusted EBITDA to measure the financial performance of our global business units and for reporting the results of our operating segments. This measure includes all operating items relating to the businesses. The adjusted EBITDA of operating segments excludes items that principally apply to our Company as a whole. The following schedule includes revenues and adjusted EBITDA for each of our reportable operating segments (dollars in millions).

	*Three months*
	*ended*
	*March 31,*
	*2023*			*2022*
Revenues:
Polyurethanes	$	991		$	1,386
Performance Products		334			480
Advanced Materials		289			335
Total reportable segments’ revenues		1,614			2,201
Intersegment eliminations		(8	)		(9	)
Total	$	1,606		$	2,192

Huntsman Corporation:
Segment adjusted EBITDA(1):
Polyurethanes	$	66		$	224
Performance Products		71			146
Advanced Materials		48			67
Total reportable segments’ adjusted EBITDA		185			437

Reconciliation of total reportable segments’ adjusted EBITDA to income from continuing operations before income taxes:
Interest expense, net—continuing operations		(18	)		(14	)
Depreciation and amortization—continuing operations		(69	)		(67	)
Corporate and other costs, net(2)		(49	)		(50	)
Net income attributable to noncontrolling interests		13			17
Other adjustments:
Business acquisition and integration expenses and purchase accounting inventory adjustments		(1	)		(6	)
Fair value adjustments to Venator investment, net		(1	)		(2	)
Certain legal and other settlements and related expenses		(1	)		(12	)
Costs associated with the Albemarle Settlement, net		—			(1	)
Loss on sale of business/assets		—			(4	)
Income from transition services arrangements		—			1
Certain nonrecurring information technology project implementation costs		(2	)		(2	)
Amortization of pension and postretirement actuarial losses		(8	)		(12	)
Restructuring, impairment and plant closing and transition credits (costs)(3)		6			(3	)
Income from continuing operations before income taxes		55			282

Income tax expense—continuing operations		(11	)		(60	)
Income from discontinued operations, net of tax		122			18
Net income	$	166		$	240

Table of Contents

	*Three months*
	*ended*
	*March 31,*
	*2023*			*2022*
Huntsman International:
Segment adjusted EBITDA(1):
Polyurethanes	$	66		$	224
Performance Products		71			146
Advanced Materials		48			67
Total reportable segments’ adjusted EBITDA		185			437

Reconciliation of total reportable segments’ adjusted EBITDA to income from continuing operations before income taxes:
Interest expense, net—continuing operations		(18	)		(14	)
Depreciation and amortization—continuing operations		(69	)		(67	)
Corporate and other costs, net(2)		(47	)		(47	)
Net income attributable to noncontrolling interests		13			17
Other adjustments:
Business acquisition and integration expenses and purchase accounting inventory adjustments		(1	)		(6	)
Fair value adjustments to Venator investment, net		(1	)		(2	)
Certain legal and other settlements and related expenses		(1	)		(12	)
Costs associated with the Albemarle Settlement, net		—			(1	)
Loss on sale of business/assets		—			(4	)
Income from transition services arrangements		—			1
Certain nonrecurring information technology project implementation costs		(2	)		(2	)
Amortization of pension and postretirement actuarial losses		(8	)		(12	)
Restructuring, impairment and plant closing and transition credits (costs)(3)		6			(3	)
Income from continuing operations before income taxes		57			285

Income tax expense—continuing operations		(11	)		(60	)
Income from discontinued operations, net of tax		122			18
Net income	$	168		$	243

(1)

We use segment adjusted EBITDA as the measure of each segment’s profit or loss. We believe that segment adjusted EBITDA more accurately reflects what the chief operating decision maker uses to make decisions about resources to be allocated to the segments and assess their financial performance. Segment adjusted EBITDA is defined as net income of Huntsman Corporation or Huntsman International, as appropriate, before interest, income tax, depreciation and amortization, net income attributable to noncontrolling interests and certain Corporate and other items, as well as eliminating the following adjustments: (a) business acquisition and integration expenses and purchase accounting inventory adjustments; (b) fair value adjustments to Venator investment, net; (c) certain legal and other settlements and related expenses; (d) costs associated with the Albemarle Settlement, net; (e) loss on sale of business/assets; (f) income from transition services arrangements; (g) certain nonrecurring information technology project implementation costs; (h) amortization of pension and postretirement actuarial losses; (i) restructuring, impairment, plant closing and transition credits (costs); and (j) income from discontinued operations, net of tax.

(2)	Corporate and other costs, net includes unallocated corporate overhead, unallocated foreign currency exchange gains and losses, LIFO inventory valuation reserve adjustments, nonoperating income and expense and gains and losses on the disposition of corporate assets.

(3)	Includes costs associated with transition activities related primarily to our Corporate program to optimize our global approach to leverage shared services capabilities.

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Results of Operations

As discussed in “Note 3. Discontinued Operations and Business Disposition—Sale of Textile Effects Business” to our condensed consolidated financial statements, the results from continuing operations primarily exclude the results of our Textile Effects Business for all periods presented. For each of our Company and Huntsman International, the following tables set forth the condensed consolidated results of operations from continuing operations (dollars in millions, except per share amounts):

Huntsman Corporation

	Three months
	ended
	March 31,						Percent
	2023			2022			change
Revenues	$	1,606		$	2,192			(27	)%
Cost of goods sold		1,337			1,677			(20	)%
Gross profit		269			515			(48	)%
Operating expenses, net		215			232			(7	)%
Restructuring, impairment and plant closing credits		(7	)		—			NM
Operating income		61			283			(78	)%
Interest expense, net		(18	)		(14	)		29	%
Equity in income of investment in unconsolidated affiliates		12			15			(20	)%
Fair value adjustments to Venator investment, net		(1	)		(2	)		(50	)%
Other income, net		1			—			NM
Income from continuing operations before income taxes		55			282			(80	)%
Income tax expense		(11	)		(60	)		(82	)%
Income from continuing operations		44			222			(80	)%
Income from discontinued operations, net of tax(1)		122			18			578	%
Net income		166			240			(31	)%
Reconciliation of net income to adjusted EBITDA:
Net income attributable to noncontrolling interests		(13	)		(17	)		(24	)%
Interest expense, net from continuing operations		18			14			29	%
Income tax expense from continuing operations		11			60			(82	)%
Income tax expense from discontinued operations		15			5			200	%
Depreciation and amortization from continuing operations		69			67			3	%
Depreciation and amortization from discontinued operations		—			4			(100	)%
Other adjustments:
Business acquisition and integration expenses and purchase accounting inventory adjustments		1			6
EBITDA from discontinued operations(1)		(137	)		(27	)
Fair value adjustments to Venator investment, net		1			2
Certain legal and other settlements and related expenses		1			12
Costs associated with the Albemarle Settlement, net		—			1
Loss on sale of business/assets		—			4
Income from transition services arrangements		—			(1	)
Certain nonrecurring information technology project implementation costs		2			2
Amortization of pension and postretirement actuarial losses		8			12
Restructuring, impairment and plant closing and transition (credits) costs(2)		(6	)		3
Adjusted EBITDA(3)	$	136		$	387			(65	)%

Net cash (used in) provided by operating activities from continuing operations	$	(122	)	$	67			NM
Net cash provided by (used in) investing activities from continuing operations		493			(60	)		NM
Net cash used in financing activities		(379	)		(252	)		50	%
Capital expenditures from continuing operations		(46	)		(64	)		(28	)%

Table of Contents

Huntsman International

	Three months
	ended
	March 31,						Percent
	2023			2022			change
Revenues	$	1,606		$	2,192			(27	)%
Cost of goods sold		1,337			1,677			(20	)%
Gross profit		269			515			(48	)%
Operating expenses, net		213			229			(7	)%
Restructuring, impairment and plant closing credits		(7	)		—			NM
Operating income		63			286			(78	)%
Interest expense, net		(18	)		(14	)		29	%
Equity in income of investment in unconsolidated affiliates		12			15			(20	)%
Fair value adjustments to Venator investment, net		(1	)		(2	)		(50	)%
Other income, net		1			—			NM
Income from continuing operations before income taxes		57			285			(80	)%
Income tax expense		(11	)		(60	)		(82	)%
Income from continuing operations		46			225			(80	)%
Income from discontinued operations, net of tax(1)		122			18			578	%
Net income		168			243			(31	)%
Reconciliation of net income to adjusted EBITDA:
Net income attributable to noncontrolling interests		(13	)		(17	)		(24	)%
Interest expense, net from continuing operations		18			14			29	%
Income tax expense from continuing operations		11			60			(82	)%
Income tax expense from discontinued operations		15			5			200	%
Depreciation and amortization from continuing operations		69			67			3	%
Depreciation and amortization from discontinued operations		—			4			(100	)%
Other adjustments:
Business acquisition and integration expenses and purchase accounting inventory adjustments		1			6
EBITDA from discontinued operations(1)		(137	)		(27	)
Fair value adjustments to Venator investment, net		1			2
Certain legal and other settlements and related expenses		1			12
Costs associated with the Albemarle Settlement, net		—			1
Loss on sale of business/assets		—			4
Income from transition services arrangements		—			(1	)
Certain nonrecurring information technology project implementation costs		2			2
Amortization of pension and postretirement actuarial losses		8			12
Restructuring, impairment and plant closing and transition (credits) costs(2)		(6	)		3
Adjusted EBITDA(3)	$	138		$	390			(65	)%

Net cash (used in) provided by operating activities from continuing operations	$	(122	)	$	68			NM
Net cash provided by (used in) investing activities from continuing operations		385			(273	)		NM
Net cash used in financing activities		(271	)		(39	)		595	%
Capital expenditures from continuing operations		(46	)		(64	)		(28	)%

Table of Contents

Huntsman Corporation

	Three months									Three months
	ended									ended
	March 31, 2023									March 31, 2022
				Tax and									Tax and
	Gross			other(4)			Net			Gross			other(4)			Net
Reconciliation of net income to adjusted net income
Net income							$	166								$	240
Net income attributable to noncontrolling interests								(13	)								(17	)
Business acquisition and integration expenses and purchase accounting inventory adjustments	$	1		$	—			1		$	6		$	—			6
Income from discontinued operations(1)(5)		(137	)		15			(122	)		(27	)		9			(18	)
Fair value adjustments to Venator investment, net		1			—			1			2			—			2
Certain legal and other settlements and related expenses		1			—			1			12			(4	)		8
Costs associated with the Albemarle Settlement, net		—			—			—			1			—			1
Loss on sale of business/assets		—			—			—			4			(1	)		3
Income from transition services arrangements		—			—			—			(1	)		—			(1	)
Certain nonrecurring information technology project implementation costs		2			—			2			2			—			2
Amortization of pension and postretirement actuarial losses		8			(1	)		7			12			(3	)		9
Restructuring, impairment and plant closing and transition (credits) costs(2)		(6	)		—			(6	)		3			(1	)		2
Adjusted net income(3)							$	37								$	237

Weighted average shares-basic								182.7									212.7
Weighted average shares-diluted								184.4									215.4

Basic net income attributable to Huntsman Corporation per share:
Income from continuing operations							$	0.17								$	0.96
Income from discontinued operations								0.67									0.09
Net income							$	0.84								$	1.05

Diluted net income attributable to Huntsman Corporation per share:
Income from continuing operations							$	0.17								$	0.95
Income from discontinued operations								0.66									0.09
Net income							$	0.83								$	1.04

Other non-GAAP measures:
Diluted adjusted net income per share(3)							$	0.20								$	1.10

Net cash (used in) provided by operating activities from continuing operations							$	(122	)							$	67
Capital expenditures from continuing operations								(46	)								(64	)
Free cash flow from continuing operations(3)							$	(168	)							$	3

Effective tax rate								20	%								21	%
Impact of non-GAAP adjustments(6)								(1	)%								—
Adjusted effective tax rate								19	%								21	%

NM—Not meaningful

(1)	Includes the gain on the sale of our Textile Effects Business in the first quarter of 2023.

(2)	Includes costs associated with transition activities related primarily to our Corporate program to optimize our global approach to leverage shared services capabilities.

(3)	See “—Non-GAAP Financial Measures.”

(4)	The income tax impacts, if any, are computed on the pre-tax adjustments using a with and without approach.

(5)	In addition to income tax impacts, this adjusting item is also impacted by depreciation and amortization expense and interest expense.

(6)	For details regarding the tax impacts of our non-GAAP adjustments, please see the reconciliation of our net income to adjusted net income noted above.

Table of Contents

Non-GAAP Financial Measures

Our condensed consolidated financial statements are prepared in accordance with GAAP, which we supplement with certain non-GAAP financial information. These non-GAAP measures should not be considered in isolation or as a substitute for the related GAAP measures, and other companies may define such measures differently. We encourage investors to review our financial statements and the reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures in their entirety and not to rely on any single financial measure. These non-GAAP measures exclude the impact of certain income and expenses that we do not believe are indicative of our core operating results.

Adjusted EBITDA

Our management uses adjusted EBITDA to assess financial performance. Adjusted EBITDA is defined as net income of Huntsman Corporation or Huntsman International, as appropriate, before interest, income tax, depreciation and amortization, net income attributable to noncontrolling interests and certain Corporate and other items, as well as eliminating the following adjustments: (a) business acquisition and integration expenses and purchase accounting inventory adjustments; (b) EBITDA from discontinued operations; (c) fair value adjustments to Venator investment, net; (d) certain legal and other settlements and related expenses; (e) costs associated with the Albemarle Settlement, net; (f) loss on sale of business/assets; (g) income from transition services arrangements; (h) certain nonrecurring information technology project implementation costs; (i) amortization of pension and postretirement actuarial losses; and (j) restructuring, impairment and plant closing and transition (credits) costs. We believe that net income of Huntsman Corporation or Huntsman International, as appropriate, is the performance measure calculated and presented in accordance with U.S. GAAP that is most directly comparable to adjusted EBITDA.

We believe adjusted EBITDA is useful to investors in assessing the businesses’ ongoing financial performance and provides improved comparability between periods through the exclusion of certain items that management believes are not indicative of the businesses’ operational profitability and that may obscure underlying business results and trends. However, this measure should not be considered in isolation or viewed as a substitute for net income of Huntsman Corporation or Huntsman International, as appropriate, or other measures of performance determined in accordance with U.S. GAAP. Moreover, adjusted EBITDA as used herein is not necessarily comparable to other similarly titled measures of other companies due to potential inconsistencies in the methods of calculation. Our management believes this measure is useful to compare general operating performance from period to period and to make certain related management decisions. Adjusted EBITDA is also used by securities analysts, lenders and others in their evaluation of different companies because it excludes certain items that can vary widely across different industries or among companies within the same industry. For example, interest expense can be highly dependent on a company’s capital structure, debt levels and credit ratings. Therefore, the impact of interest expense on earnings can vary significantly among companies. In addition, the tax positions of companies can vary because of their differing abilities to take advantage of tax benefits and because of the tax policies of the various jurisdictions in which they operate. As a result, effective tax rates and tax expense can vary considerably among companies. Finally, companies employ productive assets of different ages and utilize different methods of acquiring and depreciating such assets. This can result in considerable variability in the relative costs of productive assets and the depreciation and amortization expense among companies.

Nevertheless, our management recognizes that there are material limitations associated with the use of adjusted EBITDA in the evaluation of our Company as compared to net income of Huntsman Corporation or Huntsman International, as appropriate, which reflects overall financial performance. For example, we have borrowed money in order to finance our operations and interest expense is a necessary element of our costs and ability to generate revenue. Our management compensates for the limitations of using adjusted EBITDA by using this measure to supplement U.S. GAAP results to provide a more complete understanding of the factors and trends affecting the business rather than U.S. GAAP results alone.

Table of Contents

Adjusted Net Income

Adjusted net income is computed by eliminating the after-tax amounts related to the following from net income attributable to Huntsman Corporation: (a) business acquisition and integration expenses and purchase accounting inventory adjustments; (b) income from discontinued operations; (c) fair value adjustments to Venator investment, net; (d) certain legal and other settlements and related expenses; (e) costs associated with the Albemarle Settlement, net; (f) loss on sale of business/assets; (g) income from transition services arrangements; (h) certain nonrecurring information technology project implementation costs; (i) amortization of pension and postretirement actuarial losses; and (j) restructuring, impairment and plant closing and transition (credits) costs. Basic adjusted net income per share excludes dilution and is computed by dividing adjusted net income by the weighted average number of shares outstanding during the period. Adjusted diluted net income per share reflects all potential dilutive common shares outstanding during the period and is computed by dividing adjusted net income by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding as dilutive securities. Adjusted net income and adjusted net income per share amounts are presented solely as supplemental information.

We believe adjusted net income is useful to investors in assessing the businesses’ ongoing financial performance and provides improved comparability between periods through the exclusion of certain items that management believes are not indicative of the businesses’ operational profitability and that may obscure underlying business results and trends.

Free Cash Flow

We believe free cash flow is an important indicator of our liquidity as it measures the amount of cash we generate. Management internally uses a free cash flow measure: (a) to evaluate our liquidity, (b) evaluate strategic investments, (c) plan stock buyback and dividend levels and (d) evaluate our ability to incur and service debt.

Adjusted Effective Tax Rate

We believe that the effective tax rate of Huntsman Corporation or Huntsman International, as appropriate, is the performance measure calculated and presented in accordance with U.S. GAAP that is most directly comparable to adjusted effective tax rate. We believe our adjusted effective tax rate provides improved comparability between periods through the exclusion of certain items, such as, business acquisition and integration expenses and purchase accounting inventory adjustments, certain legal and other settlements and related expenses, gains on sale of businesses/assets and certain tax only items, including tax law changes not yet enacted, that we believe are not indicative of the businesses’ operational profitability and that may obscure underlying business results and trends.

Our forward-looking adjusted effective tax rate is calculated based on our forecast effective tax rate, and the range of our forward-looking adjusted effective tax rate equals the range of our forecast effective tax rate. We disclose forward-looking adjusted effective tax rate because we cannot adequately forecast certain items and events that may or may not impact us in the near future, such as business acquisition and integration expenses and purchase accounting inventory adjustments, certain legal and other settlements and related expenses, gains on sale of businesses/assets and certain tax only items, including tax law changes not yet enacted. Each of such adjustment has not yet occurred, is out of our control and/or cannot be reasonably predicted. In our view, our forward-looking adjusted effective tax rate represents the forecast effective tax rate on our underlying business operations but does not reflect any adjustments related to the items noted above that may occur and can cause our effective tax rate to differ.

Table of Contents

Three Months Ended March 31, 2023 Compared with Three Months Ended March 31, 2022

For the three months ended March 31, 2023, income from continuing operations attributable to Huntsman Corporation was $31 million, a decrease of $174 million from $205 million in the 2022 period. For the three months ended March 31, 2023, income from continuing operations attributable to Huntsman International was $33 million, a decrease of $175 million from $208 million in the 2022 period. The decreases noted above were the result of the following items:

●

Revenues for the three months ended March 31, 2023 decreased by $586 million, or 27%, as compared with the 2022 period. The decrease was primarily due to lower sales volumes in all our segments, partially offset by higher average selling prices in our Advanced Materials segment. See “—Segment Analysis” below.

●

Gross profit for the three months ended March 31, 2023 decreased by $246 million, or 48%, as compared with the 2022 period. The decrease resulted primarily from lower gross profits in all our segments. See “—Segment Analysis” below.

●

Our operating expenses, net and the operating expenses, net of Huntsman International for the three months ended March 31, 2023 decreased by $17 million and $16 million, respectively, or 7% for both, as compared with the 2022 period, primarily related to a decrease in selling, general and administrative expenses as well as the impact of translating foreign currency amounts to the U.S. dollar.

●

Restructuring, impairment and plant closing credits were $7 million for the three months ended March 31, 2023 as compared with nil in the 2022 period. For further information, see “Note 6. Restructuring, Impairment and Plant Closing Costs” to our condensed consolidated financial statements.

●

Income tax expense for the three months ended March 31, 2023 decreased to $11 million from $60 million in the 2022 period. The decrease in income tax expense was primarily due to the decrease in income from continuing operations before income taxes. Our income tax expense is significantly affected by the mix of income and losses in the tax jurisdictions in which we operate along with the impact of valuation allowances in certain tax jurisdictions. For further information, see “Note 17. Income Taxes” to our condensed consolidated financial statements.

	Three months						Percent
	ended						change
	March 31,						favorable
(Dollars in millions)	2023			2022			(unfavorable)
Revenues
Polyurethanes	$	991		$	1,386			(28	)%
Performance Products		334			480			(30	)%
Advanced Materials		289			335			(14	)%
Total reportable segments’ revenues		1,614			2,201			(27	)%
Intersegment eliminations		(8	)		(9	)		NM
Total	$	1,606		$	2,192			(27	)%

Huntsman Corporation
Segment adjusted EBITDA(1)
Polyurethanes	$	66		$	224			(71	)%
Performance Products		71			146			(51	)%
Advanced Materials		48			67			(28	)%
Total reportable segments’ adjusted EBITDA		185			437			(58	)%
Corporate and other		(49	)		(50	)		2	%
Total	$	136		$	387			(65	)%

Huntsman International
Segment adjusted EBITDA(1)
Polyurethanes	$	66		$	224			(71	)%
Performance Products		71			146			(51	)%
Advanced Materials		48			67			(28	)%
Total reportable segments’ adjusted EBITDA		185			437			(58	)%
Corporate and other		(47	)		(47	)		—
Total	$	138		$	390			(65	)%

NM—Not meaningful

(1)

For further information, including reconciliation of total reportable segments’ adjusted EBITDA to income from continuing operations before income taxes of Huntsman Corporation or Huntsman International, as appropriate, see “Note 19. Operating Segment Information” to our condensed consolidated financial statements.

Table of Contents

	Three months ended March 31, 2023 vs 2022
	Average selling price(1)
	Local			Foreign currency			Sales			Mix and
	currency			translation impact			volumes(2)			other
Period-over-period increase (decrease)
Polyurethanes		(2	)%		(3	)%		(21	)%		(2	)%
Performance Products		—			(1	)%		(31	)%		2	%
Advanced Materials		6	%		(3	)%		(21	)%		4	%

(1)	Excludes revenues from tolling arrangements, byproducts and raw materials.

(2)	Excludes sales volumes of byproducts and raw materials.

Table of Contents

Polyurethanes

The decrease in revenues in our Polyurethanes segment for the three months ended March 31, 2023 compared to the same period of 2022 was primarily due to lower sales volumes, lower MDI average selling prices and the negative impact of weaker major international currencies against the U.S. dollar. Sales volumes decreased primarily due to lower demand, particularly in our European and Americas regions. The decrease in segment adjusted EBITDA was primarily due to lower sales volumes, lower MDI margins, the negative impact of weaker major international currencies against the U.S. dollar and lower equity earnings from our minority-owned joint venture in China, partially offset by cost savings achieved from our cost optimization program.

Performance Products

The decrease in revenues in our Performance Products segment for the three months ended March 31, 2023 compared to the same period of 2022 was primarily due to lower sales volumes, partially offset by improved sales mix. Sales volumes decreased in all regions primarily due to slowing construction activity, reduced demand in coatings, adhesives, lubes and other industrial markets as well as inventory destocking. The decrease in segment adjusted EBITDA was primarily due to decreased sales volumes.

Advanced Materials

The decrease in revenues in our Advanced Materials segment for the three months ended March 31, 2023 compared to the same period of 2022 was primarily due to lower sales volumes, partially offset by higher average selling prices. Sales volumes decreased primarily due to reduced customer demand in our infrastructure markets and the deselection of lower margin business. Average selling prices increased largely in response to higher raw material, energy and logistics costs as well as improved sales mix. The decrease in segment adjusted EBITDA was primarily due to lower sales volumes.

Corporate and other

Corporate and other includes unallocated corporate overhead, unallocated foreign currency exchange gains and losses, LIFO inventory valuation reserve adjustments, loss on early extinguishment of debt, unallocated restructuring, impairment and plant closing costs, nonoperating income and expense and gains and losses on the disposition of corporate assets. For the three months ended March 31, 2023, adjusted EBITDA from Corporate and other for Huntsman Corporation was a loss of $49 million as compared to a loss of $50 million for the same period of 2022. The increase in adjusted EBITDA from Corporate and other for Huntsman Corporation resulted primarily from an increase in LIFO valuation gains, partially offset by project costs related to our cost optimization program and an increase in pension expense. For the three months ended March 31, 2023, adjusted EBITDA from Corporate and other for Huntsman International was a loss of $47 million, which remained the same as a loss of $47 million for the same period of 2022.

Table of Contents

Liquidity and Capital Resources

The following is a discussion of our liquidity and capital resources and generally does not include separate information with respect to Huntsman International in accordance with General Instructions H(1)(a) and (b) of Form 10-Q.

Cash Flows for the Three Months Ended March 31, 2023 Compared with the Three Months Ended March 31, 2022

Net cash (used in) provided by operating activities from continuing operations for the three months ended March 31, 2023 and 2022 was $(122) million and $67 million, respectively. The increase in net cash used in operating activities from continuing operations during the three months ended March 31, 2023 compared with the same period in 2022 was primarily attributable to decreased operating income as described in “—Results of Operations” above for the three months ended March 31, 2023 as compared with the same period of 2022, partially offset by a net cash inflow of $18 million related to changes in operating assets and liabilities.

Net cash provided by (used in) investing activities from continuing operations for the three months ended March 31, 2023 and 2022 was $493 million and $(60) million, respectively. During the three months ended March 31, 2023 and 2022, we paid $46 million and $64 million for capital expenditures, respectively. During the three months ended March 31, 2023, we received $541 million for the sale of businesses, net, primarily related to net proceeds of $530 million from the sale of our Textile Effects Business. See “Note 3. Discontinued Operations and Business Disposition—Sale of Textile Effects Business” to our condensed consolidated financial statements.

Net cash used in financing activities for the three months ended March 31, 2023 and 2022 was $379 million and $252 million, respectively. During the three months ended March 31, 2023, we repaid in full $220 million against the outstanding balances under our 2022 Revolving Credit Facility and our A/R Programs. During the three months ended March 31, 2023 and 2022, we paid $97 million and $203 million for repurchases of our common stock, respectively.

Free cash flow from continuing operations for the three months ended March 31, 2023 and 2022 was a use of cash of $168 million and proceeds of cash of $3 million, respectively. The decrease in free cash flow from continuing operations was primarily attributable to the increase in cash used in operating activities from continuing operations, partially offset by a decrease in cash used for capital expenditures during the three months ended March 31, 2023 as compared with the same period in 2022.

Table of Contents

Changes in Financial Condition

The following information summarizes our working capital position (dollars in millions):

	March 31,		December 31,		Increase			Percent
	2023		2022		(decrease)			change
Cash and cash equivalents	$	615	$	654	$	(39	)		(6	)%
Accounts and notes receivable, net		887		834		53			6	%
Inventories		1,048		995		53			5	%
Other current assets		150		190		(40	)		(21	)%
Current assets held for sale(1)		—		472		(472	)		(100	)%
Total current assets		2,700		3,145		(445	)		(14	)%

Accounts payable		857		961		(104	)		(11	)%
Accrued liabilities		381		429		(48	)		(11	)%
Current portion of debt		11		66		(55	)		(83	)%
Current operating lease liabilities		48		51		(3	)		(6	)%
Current liabilities held for sale(1)		—		194		(194	)		(100	)%
Total current liabilities		1,297		1,701		(404	)		(24	)%
Working capital	$	1,403	$	1,444	$	(41	)		(3	)%

(1)

Total assets and liabilities held for sale as of December 31, 2022 are classified as current because we completed the sale of our Textile Effects Business on February 28, 2023. For more information see “Note 3. Discontinued Operations and Business Disposition—Sale of Textile Effects Business” to our condensed consolidated financial statements.

Our working capital decreased by $41 million as a result of the net impact of the following significant changes:

●

The decrease in cash and cash equivalents of $39 million resulted from the matters identified on our condensed consolidated statements of cash flows. See also “—Cash Flows for the Three Months Ended March 31, 2023 Compared with the Three Months Ended March 31, 2022.”

●

Accounts and notes receivable, net increased by $53 million primarily due to higher revenues at the end of the first quarter of 2023 as compared with the end of the fourth quarter of 2022.

●

Inventories increased by $53 million primarily due to higher inventory costs and volumes.

●

Other current assets decreased by $40 million primarily due to amortization of deferred charges related to insurance premiums and a reduction in income taxes receivable.

●

Accounts payable decreased by $104 million primarily due to a decrease in non-trade payables related to insurance premiums and a reduction of capital accruals.

●

Accrued liabilities decreased by $48 million primarily related to a decrease in accrued compensation costs, accrued restructuring and accrued rebates.

●

Current portion of debt decreased by $55 million primarily due to the repayment in full of the outstanding balance under our 2022 Revolving Credit Facility.

Table of Contents

Short-Term Liquidity

We depend upon our cash, our 2022 Revolving Credit Facility, A/R Programs and other debt instruments to provide liquidity for our operations and working capital needs. As of March 31, 2023, we had $2,040 million of combined cash and unused borrowing capacity, consisting of $615 million in cash, $1,187 million in availability under our 2022 Revolving Credit Facility and $238 million in availability under our A/R Programs. Our liquidity can be significantly impacted by various factors. The following matters are expected to have a significant impact on our liquidity:

●

During 2023, we expect to spend between approximately $240 million to $250 million on capital expenditures. Our future expenditures include certain environmental, health and safety upgrades; expansions of our existing manufacturing and other facilities; certain cost reduction projects, including those described below; and certain information technology expenditures. We expect to fund capital expenditures with cash provided by operations.

●

During the remainder of 2023, we expect to make additional contributions to our pension and other postretirement benefit plans of approximately $28 million.

●

From April 1, 2023 through April 25, 2023, we repurchased 588,282 shares of our common stock for approximately $16 million under our share repurchase program.

●

On February 28, 2023, we completed the sale of our Textile Effects Business to Archroma and received net proceeds of $530 million, determined as the preliminary purchase price of $593 million less $5 million for certain costs paid by Archroma on our behalf, $30 million of estimated net working capital adjustments and $28 million of cash that will be reimbursed to us as part of the final post-closing adjustments anticipated in 2023. Through the first quarter of 2023, we have paid cash taxes of approximately $12 million, and we expect to pay additional cash taxes of approximately $30 million.

Long-Term Liquidity

●

During 2020, management implemented cost realignment and synergy plans. In connection with these plans, we remain committed to achieving annualized cost savings and synergy benefits of approximately $140 million during 2023, as previously communicated. During 2021, management implemented additional cost realignment plans, and in connection with these plans, we expect to achieve further annualized cost savings of approximately $100 million by the end of 2023. Associated with these plans, we expect cash costs of approximately $210 million, including approximately $30 million of capital expenditures, through 2024, of which we have spent approximately $165 million to date.

●

In early November 2022, we announced our commitment and specific plans to further realign our cost structure beyond the current in-progress cost optimization plans noted above with additional restructuring in Europe. This program will include exiting and consolidating certain facilities, workforce relocation to lower cost locations and further personnel rationalization. In connection with this program, we currently expect to achieve annualized cost savings of approximately $40 million by the end of 2023. Associated with this program, we expect cash costs of approximately $60 million, including approximately $15 million of capital expenditures, through 2024, of which we have spent approximately $3 million to date.

●

On April 29, 2022, a New Orleans jury awarded us approximately $94 million in our long-running court battle against Praxair/Linde, one of the industrial gas suppliers to our Geismar, Louisiana MDI manufacturing site. The case was filed after Praxair refused to properly maintain its own Geismar facility and then repeatedly failed to supply our requirements for industrial gas needed to manufacture MDI under long-term supply contracts that expired in 2013. After adding mandatory pre-judgment and post-judgment interest to the award, we expect damages to exceed $125 million before deducting for taxes and legal fees. The award is subject to a pending appeal, and if affirmed, we expect to receive net proceeds of approximately $50 million to $60 million. We have not yet recognized the award in our condensed consolidated statements of operations.

●

On May 20, 2022, Huntsman International entered into the 2022 Revolving Credit Facility. Borrowings will bear interest at the rates specified in the credit agreement governing the 2022 Credit Facility, which will vary based on the type of loan and Huntsman International’s debt ratings. Under the credit agreement, the interest rate margin and the commitment fee rates are also subject to adjustments based on the Company’s performance on specified sustainability target thresholds with respect to annual percentage reduction in operational greenhouse gas emissions intensity and annual percentage reduction in water consumption intensity. Unless previously terminated in accordance with its terms, the credit agreement will mature in May 2027. Huntsman International may increase the 2022 Revolving Credit Facility commitments up to an additional $500 million, subject to the satisfaction of certain conditions. See “Note 7. Debt—Direct and Subsidiary Debt—Revolving Credit Facility” to our condensed consolidated financial statements.

●

On February 17, 2023, our Board of Directors declared a $0.2375 per share cash dividend on our common stock. This represents an approximate 12% increase from the previous dividend.

As of March 31, 2023, we had $11 million classified as current portion of debt, including debt at our variable interest entities of $9 million and certain other short-term facilities and scheduled amortization payments totaling $2 million. We intend to renew, repay or extend the majority of these short-term facilities in the next twelve months.

As of March 31, 2023, we had approximately $414 million of cash and cash equivalents held by our foreign subsidiaries, including our variable interest entities. With the exception of certain amounts that we expect to repatriate in the foreseeable future, we intend to use cash held in our foreign subsidiaries to fund our local operations. Nevertheless, we could repatriate additional cash as dividends, and the repatriation of cash as a dividend would generally not be subject to U.S. taxation. However, such repatriation may potentially be subject to limited foreign withholding taxes.

For more information regarding our debt, see “Note 7. Debt” to our condensed consolidated financial statements.

Table of Contents

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

ITEM 4. CONTROLS AND PROCEDURES

Our management, with the participation of our chief executive officer and chief financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of March 31, 2023. Based on this evaluation, our chief executive officer and chief financial officer have concluded that, as of March 31, 2023, our disclosure controls and procedures were effective, in that they ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms and (2) accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.

No changes to our internal control over financial reporting occurred during the quarter ended March 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act). However, we can only give reasonable assurance that our internal controls over financial reporting will prevent or detect material misstatements on a timely basis.

Table of Contents

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

There have been no material developments with respect to the legal proceedings referenced in Part I, Item 3 of our Annual Report on Form 10-K for the year ended December 31, 2022.

ITEM 1A. RISK FACTORS

For information regarding risk factors, see “Part I. Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following table provides information with respect to shares of our common stock that we repurchased as part of our share repurchase program and shares of restricted stock granted under our stock incentive plans that we withheld upon vesting to satisfy our tax withholding obligations during the three months ended March 31, 2023.

					Total number of		Approximate dollar
					shares purchased		value of shares that
	Total number		Average		as part of publicly		may yet be purchased
	of shares		price paid		announced plans		under the plans or
	purchased		per share(1)		or programs(2)		programs(2)
January 1 - January 31		572,896	$	30.68		572,896	$	879,000,000
February 1 - February 28		1,609,144		30.06		1,351,752		839,000,000
March 1 - March 31		1,547,690		27.66		1,547,372		796,000,000
Total		3,729,730		29.16		3,472,020

(1)

Represents net purchase price per share, exclusive of any fees or commissions.

(2)

On October 26, 2021, our Board of Directors approved a share repurchase program of $1 billion. On March 25, 2022, our Board of Directors increased the authorization of our share repurchase program from $1 billion to $2 billion. The share repurchase program is supported by our free cash flow generation. Repurchases may be made in the open market, including through accelerated share repurchase programs, or in privately negotiated transactions, and repurchases may be commenced or suspended from time to time without prior notice. Shares of common stock acquired through the repurchase program are held in treasury at cost. During the first quarter of 2023, we repurchased 3,472,020 shares of our common stock for approximately $101 million, including commissions, under this share repurchase program.

Table of Contents

ITEM 6. EXHIBITS

See the Exhibit Index at the end of this Quarterly Report on Form 10-Q for exhibits filed with this report.

Table of Contents

EXHIBIT INDEX

			Incorporated by Reference
Exhibit Number		Exhibit Description	Form	Exhibit	Filing Date
31.1	**	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	**	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	**	Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	**	Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	**	Inline XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH	**	Inline XBRL Taxonomy Extension Schema
101.CAL	**	Inline XBRL Taxonomy Extension Calculation Linkbase
101.LAB	**	Inline XBRL Taxonomy Extension Label Linkbase
101.PRE	**	Inline XBRL Taxonomy Extension Presentation Linkbase
101.DEF	**	Inline XBRL Taxonomy Extension Definition Linkbase
104		The cover page from this Quarterly Report on Form 10-Q, formatted in Inline XBRL and contained in Exhibit 101

^*	Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. Huntsman agrees to furnish supplementally to the SEC a copy of any omitted schedule upon request by the SEC.
**	Filed herewith

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned thereunto duly authorized.

Dated: May 5, 2023	HUNTSMAN CORPORATION
	HUNTSMAN INTERNATIONAL LLC

	By:	/s/ PHILIP M. LISTER
		Philip M. Lister
		Executive Vice President and Chief Financial Officer
		and Manager (Principal Financial Officer)

	By:	/s/ STEVEN C. JORGENSEN
		Steven C. Jorgensen
		Vice President and Controller (Authorized Signatory and
		Principal Accounting Officer)